Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies

Cervical cancer (CC), one of the major causes of death of women throughout the world is primarily caused due to Human Papilloma Virus (HPV) 16 and 18. The early region (E) oncoproteins of HPV are associated with the etiopathogenesis and contribute to the progression of cancer. The present article co...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Critical reviews in oncology/hematology Ročník 174; s. 103675
Hlavní autori:	Bhattacharjee, Rahul, Das, Sabya Sachi, Biswal, Smruti Sudha, Nath, Arijit, Das, Debangshi, Basu, Asmita, Malik, Sumira, Kumar, Lamha, Kar, Sulagna, Singh, Sandeep Kumar, Upadhye, Vijay Jagdish, Iqbal, Danish, Almojam, Suliman, Roychoudhury, Shubhadeep, Ojha, Shreesh, Ruokolainen, Janne, Jha, Niraj Kumar, Kesari, Kavindra Kumar
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands Elsevier B.V 01.06.2022
Predmet:	Cervical cancer E proteins HPV Molecular mechanisms Signaling pathways Therapeutic targets Signaling pathways E proteins Cervical cancer Molecular mechanisms HPV Therapeutic targets
ISSN:	1040-8428, 1879-0461, 1879-0461
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Cervical cancer (CC), one of the major causes of death of women throughout the world is primarily caused due to Human Papilloma Virus (HPV) 16 and 18. The early region (E) oncoproteins of HPV are associated with the etiopathogenesis and contribute to the progression of cancer. The present article comprehensively discussed the structural organization and biological functions of all E proteins of HPV and their contribution to progression of CC with an intent to decipher the pathological hallmarks and their relationship. Additionally, the role of E proteins in reference to therapeutics will also be presented. A systematic search has been carried out for articles published in PubMed database by using combinations of different keywords with Boolean operators (AND, OR, NOT) including cervical cancer, HPV, E proteins, and signaling. From the analysis of literature review, its apparent that E proteins are the major contributor to disease progression. E1, E2, and E4 forms are mainly associated with viral integration, replication, and transcription whereas E6 and E7 act as an oncoprotein and are associated with the progression of cancer. E5 regulates cell proliferation, apoptosis, and facilitates the activity of E6 and E7. Additionally, E proteins were observed associated with numerous cell signaling pathways including PI3K/AKT, Wnt, Notch and reasonably contribute to the initiation of malignancy, cell proliferation, metastasis, and drug resistance. Knowing the role and interplay of each protein in initiation to progression of CC, their therapeutic significance has been elucidated. The present study observations demonstrate that E6 and E7 are the major cause of HPV-mediated CC progression. E1, E2, and E5 also act as a backbone for E6 and E7 and most of the current approaches have targeted E6 and E7 mediated action only. The present review illustrates the structural organization as well as function and regulation of all early proteins of HPV and their association with several cellular signaling pathways. The observations provide clue on the regulatory aspect of these proteins in initiation to progression and reasonably represent that targeting these proteins could be a novel therapeutic strategy for CC. In particular, its seemingly appears that inhibition of the activity of E6 and E7 oncoproteins may be a better selective target to delay the progression of CC. The review reaffirms the role of E proteins and encourages future studies on developing diagnostics, and most importantly therapeutics strategies targeting E6 and E7 oncoproteins to tackle CC related morbidity and mortality. [Display omitted] •Human papillomavirus (HPV) has crucial role in cervical cancer (CC) progression.•Targeting E proteins leads to improved therapy in HPV-mediated CC.•Silencing HPV oncoproteins is a promising therapeutic strategy in CC therapy.•Targeted therapeutics and advanced diagnostic tools to enhance the treatment strategies of HPV-mediated CC.
AbstractList	Cervical cancer (CC), one of the major causes of death of women throughout the world is primarily caused due to Human Papilloma Virus (HPV) 16 and 18. The early region (E) oncoproteins of HPV are associated with the etiopathogenesis and contribute to the progression of cancer. The present article comprehensively discussed the structural organization and biological functions of all E proteins of HPV and their contribution to progression of CC with an intent to decipher the pathological hallmarks and their relationship. Additionally, the role of E proteins in reference to therapeutics will also be presented. A systematic search has been carried out for articles published in PubMed database by using combinations of different keywords with Boolean operators (AND, OR, NOT) including cervical cancer, HPV, E proteins, and signaling. From the analysis of literature review, its apparent that E proteins are the major contributor to disease progression. E1, E2, and E4 forms are mainly associated with viral integration, replication, and transcription whereas E6 and E7 act as an oncoprotein and are associated with the progression of cancer. E5 regulates cell proliferation, apoptosis, and facilitates the activity of E6 and E7. Additionally, E proteins were observed associated with numerous cell signaling pathways including PI3K/AKT, Wnt, Notch and reasonably contribute to the initiation of malignancy, cell proliferation, metastasis, and drug resistance. Knowing the role and interplay of each protein in initiation to progression of CC, their therapeutic significance has been elucidated. The present study observations demonstrate that E6 and E7 are the major cause of HPV-mediated CC progression. E1, E2, and E5 also act as a backbone for E6 and E7 and most of the current approaches have targeted E6 and E7 mediated action only. The present review illustrates the structural organization as well as function and regulation of all early proteins of HPV and their association with several cellular signaling pathways. The observations provide clue on the regulatory aspect of these proteins in initiation to progression and reasonably represent that targeting these proteins could be a novel therapeutic strategy for CC. In particular, its seemingly appears that inhibition of the activity of E6 and E7 oncoproteins may be a better selective target to delay the progression of CC. The review reaffirms the role of E proteins and encourages future studies on developing diagnostics, and most importantly therapeutics strategies targeting E6 and E7 oncoproteins to tackle CC related morbidity and mortality. [Display omitted] •Human papillomavirus (HPV) has crucial role in cervical cancer (CC) progression.•Targeting E proteins leads to improved therapy in HPV-mediated CC.•Silencing HPV oncoproteins is a promising therapeutic strategy in CC therapy.•Targeted therapeutics and advanced diagnostic tools to enhance the treatment strategies of HPV-mediated CC. Cervical cancer (CC), one of the major causes of death of women throughout the world is primarily caused due to Human Papilloma Virus (HPV) 16 and 18. The early region (E) oncoproteins of HPV are associated with the etiopathogenesis and contribute to the progression of cancer. The present article comprehensively discussed the structural organization and biological functions of all E proteins of HPV and their contribution to progression of CC with an intent to decipher the pathological hallmarks and their relationship. Additionally, the role of E proteins in reference to therapeutics will also be presented.PURPOSECervical cancer (CC), one of the major causes of death of women throughout the world is primarily caused due to Human Papilloma Virus (HPV) 16 and 18. The early region (E) oncoproteins of HPV are associated with the etiopathogenesis and contribute to the progression of cancer. The present article comprehensively discussed the structural organization and biological functions of all E proteins of HPV and their contribution to progression of CC with an intent to decipher the pathological hallmarks and their relationship. Additionally, the role of E proteins in reference to therapeutics will also be presented.A systematic search has been carried out for articles published in PubMed database by using combinations of different keywords with Boolean operators (AND, OR, NOT) including cervical cancer, HPV, E proteins, and signaling.METHODSA systematic search has been carried out for articles published in PubMed database by using combinations of different keywords with Boolean operators (AND, OR, NOT) including cervical cancer, HPV, E proteins, and signaling.From the analysis of literature review, its apparent that E proteins are the major contributor to disease progression. E1, E2, and E4 forms are mainly associated with viral integration, replication, and transcription whereas E6 and E7 act as an oncoprotein and are associated with the progression of cancer. E5 regulates cell proliferation, apoptosis, and facilitates the activity of E6 and E7. Additionally, E proteins were observed associated with numerous cell signaling pathways including PI3K/AKT, Wnt, Notch and reasonably contribute to the initiation of malignancy, cell proliferation, metastasis, and drug resistance. Knowing the role and interplay of each protein in initiation to progression of CC, their therapeutic significance has been elucidated. The present study observations demonstrate that E6 and E7 are the major cause of HPV-mediated CC progression. E1, E2, and E5 also act as a backbone for E6 and E7 and most of the current approaches have targeted E6 and E7 mediated action only.RESULTSFrom the analysis of literature review, its apparent that E proteins are the major contributor to disease progression. E1, E2, and E4 forms are mainly associated with viral integration, replication, and transcription whereas E6 and E7 act as an oncoprotein and are associated with the progression of cancer. E5 regulates cell proliferation, apoptosis, and facilitates the activity of E6 and E7. Additionally, E proteins were observed associated with numerous cell signaling pathways including PI3K/AKT, Wnt, Notch and reasonably contribute to the initiation of malignancy, cell proliferation, metastasis, and drug resistance. Knowing the role and interplay of each protein in initiation to progression of CC, their therapeutic significance has been elucidated. The present study observations demonstrate that E6 and E7 are the major cause of HPV-mediated CC progression. E1, E2, and E5 also act as a backbone for E6 and E7 and most of the current approaches have targeted E6 and E7 mediated action only.The present review illustrates the structural organization as well as function and regulation of all early proteins of HPV and their association with several cellular signaling pathways. The observations provide clue on the regulatory aspect of these proteins in initiation to progression and reasonably represent that targeting these proteins could be a novel therapeutic strategy for CC. In particular, its seemingly appears that inhibition of the activity of E6 and E7 oncoproteins may be a better selective target to delay the progression of CC. The review reaffirms the role of E proteins and encourages future studies on developing diagnostics, and most importantly therapeutics strategies targeting E6 and E7 oncoproteins to tackle CC related morbidity and mortality.CONCLUSIONThe present review illustrates the structural organization as well as function and regulation of all early proteins of HPV and their association with several cellular signaling pathways. The observations provide clue on the regulatory aspect of these proteins in initiation to progression and reasonably represent that targeting these proteins could be a novel therapeutic strategy for CC. In particular, its seemingly appears that inhibition of the activity of E6 and E7 oncoproteins may be a better selective target to delay the progression of CC. The review reaffirms the role of E proteins and encourages future studies on developing diagnostics, and most importantly therapeutics strategies targeting E6 and E7 oncoproteins to tackle CC related morbidity and mortality. Cervical cancer (CC), one of the major causes of death of women throughout the world is primarily caused due to Human Papilloma Virus (HPV) 16 and 18. The early region (E) oncoproteins of HPV are associated with the etiopathogenesis and contribute to the progression of cancer. The present article comprehensively discussed the structural organization and biological functions of all E proteins of HPV and their contribution to progression of CC with an intent to decipher the pathological hallmarks and their relationship. Additionally, the role of E proteins in reference to therapeutics will also be presented. A systematic search has been carried out for articles published in PubMed database by using combinations of different keywords with Boolean operators (AND, OR, NOT) including cervical cancer, HPV, E proteins, and signaling. From the analysis of literature review, its apparent that E proteins are the major contributor to disease progression. E1, E2, and E4 forms are mainly associated with viral integration, replication, and transcription whereas E6 and E7 act as an oncoprotein and are associated with the progression of cancer. E5 regulates cell proliferation, apoptosis, and facilitates the activity of E6 and E7. Additionally, E proteins were observed associated with numerous cell signaling pathways including PI3K/AKT, Wnt, Notch and reasonably contribute to the initiation of malignancy, cell proliferation, metastasis, and drug resistance. Knowing the role and interplay of each protein in initiation to progression of CC, their therapeutic significance has been elucidated. The present study observations demonstrate that E6 and E7 are the major cause of HPV-mediated CC progression. E1, E2, and E5 also act as a backbone for E6 and E7 and most of the current approaches have targeted E6 and E7 mediated action only. The present review illustrates the structural organization as well as function and regulation of all early proteins of HPV and their association with several cellular signaling pathways. The observations provide clue on the regulatory aspect of these proteins in initiation to progression and reasonably represent that targeting these proteins could be a novel therapeutic strategy for CC. In particular, its seemingly appears that inhibition of the activity of E6 and E7 oncoproteins may be a better selective target to delay the progression of CC. The review reaffirms the role of E proteins and encourages future studies on developing diagnostics, and most importantly therapeutics strategies targeting E6 and E7 oncoproteins to tackle CC related morbidity and mortality.
ArticleNumber	103675
Author	Upadhye, Vijay Jagdish Nath, Arijit Singh, Sandeep Kumar Das, Sabya Sachi Roychoudhury, Shubhadeep Biswal, Smruti Sudha Jha, Niraj Kumar Kesari, Kavindra Kumar Kar, Sulagna Almojam, Suliman Iqbal, Danish Malik, Sumira Das, Debangshi Basu, Asmita Ruokolainen, Janne Kumar, Lamha Bhattacharjee, Rahul Ojha, Shreesh
Author_xml	– sequence: 1 givenname: Rahul surname: Bhattacharjee fullname: Bhattacharjee, Rahul organization: School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha 751024, India – sequence: 2 givenname: Sabya Sachi surname: Das fullname: Das, Sabya Sachi organization: Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand 835215, India – sequence: 3 givenname: Smruti Sudha surname: Biswal fullname: Biswal, Smruti Sudha organization: Department of Life Science, National Institute of Technology Rourkela, Rourkela 769008, India – sequence: 4 givenname: Arijit surname: Nath fullname: Nath, Arijit organization: School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha 751024, India – sequence: 5 givenname: Debangshi surname: Das fullname: Das, Debangshi organization: Department of Biotechnology, Haldia Institute of Technology, Affiliated to Maulana Abul Kalam Azad University of Technology, Haldia, West Bengal 721657, India – sequence: 6 givenname: Asmita surname: Basu fullname: Basu, Asmita organization: School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha 751024, India – sequence: 7 givenname: Sumira surname: Malik fullname: Malik, Sumira organization: Amity Institute of Biotechnology, Amity University Jharkhand, Ranchi, Jharkhand 834001, India – sequence: 8 givenname: Lamha surname: Kumar fullname: Kumar, Lamha organization: School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, India – sequence: 9 givenname: Sulagna surname: Kar fullname: Kar, Sulagna organization: School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha 751024, India – sequence: 10 givenname: Sandeep Kumar surname: Singh fullname: Singh, Sandeep Kumar organization: Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand 835215, India – sequence: 11 givenname: Vijay Jagdish surname: Upadhye fullname: Upadhye, Vijay Jagdish organization: Center of Research for Development (CR4D), Parul Institute of Applied Sciences (PIAS), PO Limda, Tal Waghodia 391760 Vadodara Gujarat – sequence: 12 givenname: Danish surname: Iqbal fullname: Iqbal, Danish organization: Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al-Majmaah 11952, Saudi Arabia – sequence: 13 givenname: Suliman surname: Almojam fullname: Almojam, Suliman organization: Vector-borne & Zoonotic Diseases General Directorate, Ministry of Health, Riyadh 11176, Saudi Arabia – sequence: 14 givenname: Shubhadeep surname: Roychoudhury fullname: Roychoudhury, Shubhadeep organization: Department of Life Science and Bioinformatics, Assam University, Silchar, India – sequence: 15 givenname: Shreesh surname: Ojha fullname: Ojha, Shreesh organization: Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box: 15551 Al Ain, United Arab Emirates – sequence: 16 givenname: Janne surname: Ruokolainen fullname: Ruokolainen, Janne organization: Department of Applied Physics, School of Science, Aalto University, Espoo 00076, Finland – sequence: 17 givenname: Niraj Kumar surname: Jha fullname: Jha, Niraj Kumar email: niraj.jha@sharda.ac.in organization: Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida 201306, India – sequence: 18 givenname: Kavindra Kumar surname: Kesari fullname: Kesari, Kavindra Kumar email: kavindra.kesari@aalto.fi organization: Department of Applied Physics, School of Science, Aalto University, Espoo 00076, Finland
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/35381343$$D View this record in MEDLINE/PubMed
BookMark	eNqNkU1v1DAQhi1URD_gLyAfuWTrrzgOBwRUlCK1ggNwtZzJpOsl6yy2d9FK_HgcbSuknvbkkfXOM5p5zslJmAISQjlbcMb15WoB0eeIuynAQjAhyrfUTf2MnHHTtBVTmp-UmilWGSXMKTlPacUYU0o3L8iprKXhUskz8vcOYemCT9kDjdOIdBrozbeflUtpAu8y9hRdHPd0E6eMPiTqAwWMOw9upOBCqd_Su9IJ29FFunF5-cftE3Whp9nFe5wReYnRbXA7T0k5Fuy9x_SSPB_cmPDVw3tBflx_-n51U91-_fzl6sNtBcrwXEnWGTBSaVULDaLunFYITWewxrYdWqPN0KgGeg1cuL5upex4a7pGCDGIoZEX5M2BW3b4vcWU7donwHF0AadtskKrRteK16ZEXz9Et90ae7uJfu3i3j5erATeHQIQp5QiDhZ8dtlPoazlR8uZnRXZlf2vyM6K7EFRAZgngMcZR7R-PLRiOdbOY7QJPBYDvY8I2faTPwby_gkERh9mm79wfxziHw7qycg
CitedBy_id	crossref_primary_10_1038_s41598_024_74399_0 crossref_primary_10_1155_2022_5231022 crossref_primary_10_3390_cimb46100661 crossref_primary_10_5498_wjp_v15_i6_105568 crossref_primary_10_1038_s41392_024_02083_w crossref_primary_10_3390_vaccines12111291 crossref_primary_10_3389_fonc_2024_1488730 crossref_primary_10_1016_j_cca_2024_119687 crossref_primary_10_3390_ph18091349 crossref_primary_10_1007_s10565_024_09949_3 crossref_primary_10_1016_j_amjmed_2024_06_018 crossref_primary_10_3389_fonc_2025_1508173 crossref_primary_10_3390_biom13101474 crossref_primary_10_1111_prd_12566 crossref_primary_10_3390_ijms25147616 crossref_primary_10_1038_s41598_023_45339_1 crossref_primary_10_3390_biology13020077 crossref_primary_10_1016_j_abb_2022_109449 crossref_primary_10_1007_s12672_025_02384_8 crossref_primary_10_3390_ijms26178463 crossref_primary_10_3390_ijms26062493 crossref_primary_10_1186_s13027_024_00581_8 crossref_primary_10_1002_ctm2_70305 crossref_primary_10_2147_OTT_S475132 crossref_primary_10_1016_j_critrevonc_2022_103753 crossref_primary_10_3389_fonc_2023_1143691 crossref_primary_10_1016_j_tvr_2024_200312 crossref_primary_10_3390_ijms241914555 crossref_primary_10_3390_v16030327 crossref_primary_10_1016_j_tvr_2024_200309 crossref_primary_10_24060_2076_3093_2023_13_4_320_329 crossref_primary_10_3389_fcimb_2024_1443868 crossref_primary_10_3390_cancers17091558 crossref_primary_10_3390_vaccines12060616 crossref_primary_10_1002_rmv_2537 crossref_primary_10_25259_ijmr_212_24 crossref_primary_10_1017_erm_2024_30 crossref_primary_10_1016_j_prp_2024_155612 crossref_primary_10_3390_microorganisms13051000 crossref_primary_10_32604_biocell_2024_049092 crossref_primary_10_1007_s13205_025_04250_4 crossref_primary_10_1016_j_ejogrb_2025_114686 crossref_primary_10_7717_peerj_18601 crossref_primary_10_3892_etm_2024_12671 crossref_primary_10_1007_s12010_023_04762_w crossref_primary_10_1128_jvi_00562_25 crossref_primary_10_1016_j_drup_2023_100937 crossref_primary_10_3389_fonc_2022_977933 crossref_primary_10_1093_jmcb_mjae046 crossref_primary_10_1177_11795549241254781 crossref_primary_10_1007_s12032_025_02711_7 crossref_primary_10_1080_17435889_2025_2501919 crossref_primary_10_3390_pathogens12040564 crossref_primary_10_1186_s13027_023_00560_5 crossref_primary_10_3390_ph16040622 crossref_primary_10_2217_fvl_2022_0180 crossref_primary_10_1007_s00432_024_05952_7 crossref_primary_10_2478_abm_2022_0022 crossref_primary_10_1186_s12985_025_02783_x crossref_primary_10_1186_s13063_024_08366_5 crossref_primary_10_1016_j_adcanc_2022_100050 crossref_primary_10_2174_0109298673281823231222065616 crossref_primary_10_1038_s41418_023_01242_w crossref_primary_10_3390_v17030367 crossref_primary_10_1016_j_biopha_2024_117519 crossref_primary_10_2147_JIR_S494622 crossref_primary_10_24060_2076_3093_2024_14_2_116_126 crossref_primary_10_1016_j_jddst_2024_106568 crossref_primary_10_1007_s11596_024_2898_7 crossref_primary_10_1038_s41522_024_00613_6 crossref_primary_10_3390_cancers15164082 crossref_primary_10_3390_v16030416 crossref_primary_10_1186_s12985_025_02738_2 crossref_primary_10_1177_09287329241291323 crossref_primary_10_3390_cancers16213717 crossref_primary_10_1016_j_drudis_2023_103577 crossref_primary_10_1002_jmv_28789 crossref_primary_10_1002_mc_23656 crossref_primary_10_3892_or_2025_8964 crossref_primary_10_1016_j_ijbiomac_2025_144542 crossref_primary_10_3389_fimmu_2025_1561572 crossref_primary_10_4236_jbm_2025_137014 crossref_primary_10_1038_s41388_025_03463_4 crossref_primary_10_1016_j_bbcan_2025_189292 crossref_primary_10_3390_ijms26010056 crossref_primary_10_3390_genes14061141 crossref_primary_10_3390_microorganisms11061417 crossref_primary_10_1007_s44211_025_00807_8 crossref_primary_10_1186_s12985_023_02001_6 crossref_primary_10_1002_jmv_29480 crossref_primary_10_1177_11779322241304666 crossref_primary_10_3390_biology12050661 crossref_primary_10_1016_j_micinf_2024_105315 crossref_primary_10_37349_emed_2025_1001292 crossref_primary_10_2147_IJGM_S473133 crossref_primary_10_1007_s13402_023_00806_9 crossref_primary_10_1038_s41598_025_00483_8 crossref_primary_10_3389_fimmu_2023_1267950 crossref_primary_10_3390_biology12070941 crossref_primary_10_1080_14786419_2025_2490046 crossref_primary_10_1093_hmg_ddaf027 crossref_primary_10_1016_j_micron_2023_103520 crossref_primary_10_1080_15592294_2025_2451551 crossref_primary_10_1016_j_tvr_2025_200315 crossref_primary_10_3389_fimmu_2025_1573576 crossref_primary_10_1186_s13027_025_00682_y crossref_primary_10_26538_tjnpr_v8i11_11 crossref_primary_10_3390_v16010113 crossref_primary_10_1007_s00404_022_06748_1 crossref_primary_10_3390_ijms252312991 crossref_primary_10_3390_cells13231972 crossref_primary_10_1016_j_cellsig_2025_112042 crossref_primary_10_1038_s41419_024_06932_y crossref_primary_10_1007_s10528_025_11144_w
Cites_doi	10.1186/1471-2407-4-59 10.1101/gad.988902 10.1128/JVI.76.23.12162-12172.2002 10.3390/cancers14010193 10.1016/j.virol.2010.01.034 10.1038/nrc2886 10.1242/jcs.061978 10.1016/j.arcmed.2014.10.008 10.1111/1523-1747.ep12371705 10.1016/j.virusres.2016.10.017 10.1016/j.tvr.2021.200213 10.1128/JVI.02063-08 10.1016/S2214-109X(19)30482-6 10.1074/jbc.M508455200 10.1016/j.virol.2013.07.020 10.1128/JVI.72.3.2113-2124.1998 10.1371/journal.pone.0168280 10.1128/jvi.70.11.7535-7539.1996 10.1016/j.canlet.2009.09.022 10.1038/sj.onc.1207442 10.1128/jvi.71.5.3853-3863.1997 10.1128/JVI.02158-10 10.1128/JVI.76.24.13039-13048.2002 10.1016/j.virol.2004.03.033 10.1200/JCO.2014.58.9093 10.1016/S1201-9712(07)60015-0 10.1128/JVI.79.6.3737-3747.2005 10.1177/1933719111432874 10.1101/gad.1214704 10.1016/j.omto.2021.12.011 10.1016/j.vaccine.2017.05.069 10.3727/096504015X14496932933610 10.1007/s13402-011-0069-x 10.1038/nrmicro3569 10.1128/JVI.00670-11 10.1016/j.critrevonc.2021.103343 10.1007/s00018-005-5561-x 10.1016/j.ejca.2013.07.140 10.1038/sj.onc.1208701 10.1007/s11033-010-0576-2 10.1172/jci.insight.89829 10.1371/journal.pone.0084506 10.1016/j.critrevonc.2020.103178 10.3390/v7072785 10.2741/e808 10.1158/0008-5472.CAN-06-0499 10.1128/JVI.78.7.3533-3541.2004 10.1038/nature12881 10.1128/jvi.71.1.362-370.1997 10.1038/nature16481 10.1073/pnas.88.21.9804 10.1016/S0140-6736(15)00239-1 10.1038/sj.onc.1205668 10.1073/pnas.0505337102 10.1016/j.jadohealth.2010.01.016 10.1126/scitranslmed.3004414 10.1128/jvi.67.6.3142-3150.1993 10.1093/emboj/18.9.2449 10.1038/onc.2011.455 10.1006/viro.1996.0475 10.1038/sj.onc.1202960 10.1073/pnas.92.14.6414 10.1016/j.critrevonc.2020.103111 10.1038/sj.onc.1210725 10.1517/14712598.2013.810716 10.1111/j.1398-9219.2004.00204.x 10.1126/scisignal.aag1064 10.1172/jci.insight.99488 10.1016/j.celrep.2014.05.012 10.18632/oncotarget.5283 10.1016/0092-8674(88)90570-3 10.1016/j.ygyno.2006.11.023 10.1128/AAC.49.12.4834-4842.2005 10.1038/nature21386 10.3390/v9080233 10.1016/j.virol.2013.07.008 10.1016/j.ygyno.2006.03.036 10.1016/j.yexcr.2005.01.015 10.1016/j.antiviral.2006.03.014 10.1038/srep13446 10.1073/pnas.94.13.6670 10.1016/S0042-6822(03)00129-6 10.1093/carcin/bgu102 10.1016/j.currproblcancer.2018.03.003 10.1038/s41598-018-37665-6 10.1128/jvi.67.10.6170-6178.1993 10.3389/fmicb.2019.03116 10.1073/pnas.89.10.4549 10.2174/1874357901105010080 10.1016/j.bbrc.2013.04.060 10.1073/pnas.96.4.1291 10.1097/CEJ.0b013e328364f273 10.1128/JVI.01879-14 10.1038/nrg1427 10.1016/j.bpobgyn.2017.08.006 10.1128/JVI.78.3.1333-1343.2004 10.4161/cbt.3.11.1215 10.1016/j.virol.2013.05.006 10.1016/0092-8674(91)90529-8 10.1093/emboj/18.18.5061 10.1128/JVI.00232-07 10.1128/JVI.01240-08 10.1021/bi0019592 10.1128/JVI.00196-06 10.1016/j.currproblcancer.2019.06.008 10.1074/jbc.M101932200 10.1038/sj.cgt.7700623 10.1016/j.critrevonc.2020.103192 10.1016/j.cell.2015.12.035 10.1007/s10495-007-0163-8 10.1073/pnas.0510012103 10.1016/0092-8674(92)90249-C 10.1101/gr.164806.113 10.1016/j.pvr.2016.04.001 10.1016/S0166-3542(02)00070-0 10.1038/nature18959 10.1128/jvi.01503-21 10.1016/j.pvr.2017.12.006 10.1084/jem.20122394 10.1038/nrc798 10.1309/VQXFT880JXC7QD2W 10.1074/jbc.M303608200 10.1038/gt.2012.54 10.1371/journal.pone.0033585 10.1371/journal.ppat.1004560 10.18632/oncotarget.22036 10.1016/j.cell.2014.05.010 10.1073/pnas.0505322102 10.1128/MCB.20.21.8244-8253.2000 10.1099/0022-1317-78-11-3009 10.1006/viro.1996.0171 10.1128/JVI.77.1.673-684.2003 10.1002/ijc.31937 10.1038/nri3581 10.1586/14760584.2016.1157477 10.1007/s12275-022-1606-1 10.1038/sj.onc.1207148 10.1111/j.1471-4159.2007.04633.x 10.1093/nar/gkx1103 10.1016/j.str.2012.02.001 10.7150/ijbs.21547 10.1007/s007050070048 10.1074/jbc.M200113200 10.1093/carcin/bgp066 10.1006/viro.2001.0867 10.1073/pnas.97.23.12513 10.1128/JVI.02546-13 10.2217/fvl.10.73 10.1038/s41598-019-49886-4 10.1128/mBio.02234-14 10.1128/JVI.79.12.7889-7898.2005 10.1038/sj.onc.1210541
ContentType	Journal Article
Copyright	2022 The Authors Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Copyright_xml	– notice: 2022 The Authors – notice: Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
DBID	6I. AAFTH AAYXX CITATION NPM 7X8
DOI	10.1016/j.critrevonc.2022.103675
DatabaseName	ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic
DatabaseTitle	CrossRef PubMed MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic PubMed
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1879-0461
ExternalDocumentID	35381343 10_1016_j_critrevonc_2022_103675 S1040842822000993
Genre	Journal Article Review
GroupedDBID	--- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29F 4.4 457 4CK 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACLOT ACRLP ACRPL ACVFH ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IHE J1W KOM M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SEL SES SEW SSH SSZ T5K UDS W2D WUQ Z5R ~G- ~HD 6I. AACTN AAFTH AAIAV ABLVK ABYKQ AFKWA AJBFU AJOXV AMFUW LCYCR RIG 9DU AAYXX CITATION NPM 7X8
ID	FETCH-LOGICAL-c481t-30b8c83464526c25ba64ec7b8e5e99f9868f747cd6c12ad5933b198b7222f2f73
ISICitedReferencesCount	133
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000802026300003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1040-8428 1879-0461
IngestDate	Sat Sep 27 19:38:02 EDT 2025 Thu Apr 03 07:06:53 EDT 2025 Tue Nov 18 22:12:51 EST 2025 Sat Nov 29 07:07:50 EST 2025 Fri Feb 23 02:39:58 EST 2024 Tue Oct 14 19:24:41 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Keywords	Signaling pathways E proteins Cervical cancer Molecular mechanisms HPV Therapeutic targets
Language	English
License	This is an open access article under the CC BY license. Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c481t-30b8c83464526c25ba64ec7b8e5e99f9868f747cd6c12ad5933b198b7222f2f73
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
OpenAccessLink	https://www.clinicalkey.com/#!/content/1-s2.0-S1040842822000993
PMID	35381343
PQID	2647654158
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2647654158 pubmed_primary_35381343 crossref_citationtrail_10_1016_j_critrevonc_2022_103675 crossref_primary_10_1016_j_critrevonc_2022_103675 elsevier_sciencedirect_doi_10_1016_j_critrevonc_2022_103675 elsevier_clinicalkey_doi_10_1016_j_critrevonc_2022_103675
PublicationCentury	2000
PublicationDate	2022-06-01
PublicationDateYYYYMMDD	2022-06-01
PublicationDate_xml	– month: 06 year: 2022 text: 2022-06-01 day: 01
PublicationDecade	2020
PublicationPlace	Netherlands
PublicationPlace_xml	– name: Netherlands
PublicationTitle	Critical reviews in oncology/hematology
PublicationTitleAlternate	Crit Rev Oncol Hematol
PublicationYear	2022
Publisher	Elsevier B.V
Publisher_xml	– name: Elsevier B.V
References	Razavi, Tajiknia, Majidi, Ghandali, Mirzaei, Rahimian, Hamblin, Mirzaei (bib122) 2021; 157 Zur (bib174) 2002; 2 Kim, Oh, No, Bang, Juhnn, Song (bib85) 2009; 30 Organization (bib111) 2017; 35 Kelley, Keiger, Lee, Huibregtse (bib80) 2005; 79 Gupta, Kumar, Das (bib66) 2018; 42 Liu, Clements, Zhao, Marmorstein (bib94) 2006; 281 Vats, Cerro, Thomas, Banks, L (bib153) 2021; 11 Sun, Salmon, Yajjala, Bauer, Metzger (bib140) 2014; 10 Bharti, Singh, Bhat, Pande, Jadli (bib16) 2018; 10 Stöppler, Straight, Tsao, Schlegel, Mccance (bib139) 1996; 223 Akagi, Li, Broutian, Padilla-Nash, Xiao, Jiang, Rocco, Teknos, Kumar, Wangsa (bib2) 2014; 24 Trimble, Morrow, Kraynyak, Shen, Dallas, Yan, Edwards, Parker, Denny, Giffear, Brown, Marcozzi-Pierce, Shah, Slager, Sylvester, Khan, Broderick, Juba, Herring, Boyer, Lee, Sardesai, Weiner, Bagarazzi (bib149) 2015; 386 Cherry, Rietz, Malinkevich, Liu, Xie, Bartolowits, Davisson, Baleja, Androphy (bib35) 2013; 8 McIntosh, Laskey, Sullivan, Davy, Wang, Jackson, Griffin, Doorbar (bib100) 2010; 123 Zheng, Zhang, Rao (bib173) 2004; 3 Chaturvedi (bib30) 2010; 46 Lee, Yun, Lee, Shin, Kim, Ku (bib89) 2022 Tenaillon, Barrick, Ribeck, Deatherage, Blanchard, Dasgupta, Wu, Wielgoss, Cruveiller, Médigue (bib144) 2016; 536 Makarova, Wolf, Alkhnbashi, Costa, Shah, Saunders, Barrangou, Brouns, Charpentier, Haft, Horvath, Moineau, Mojica, Terns, Terns, White, Yakunin, Garrett, van der Oost, Backofen, Koonin (bib96) 2015; 13 Hsu, Lander, Zhang (bib73) 2014; 157 Kim, Cairns, Marouga, Sun (bib86) 2003; 10 Moody, Laimins (bib103) 2010; 10 Sima, Wang, Kong, Deng, Xu, Zhou, Xu, Meng, Lu, Wang (bib135) 2008; 13 Ojesina, Lichtenstein, Freeman, Pedamallu, Imaz-Rosshandler, Pugh, Cherniack, Ambrogio, Cibulskis, Bertelsen (bib110) 2014; 506 De Nola, Loizzi, Cicinelli, Cormio (bib42) 2021; 162 Jin, Campbell, Draper, Stevanović, Weissbrich, Yu, Restifo, Rosenberg, Trimble, Hinrichs (bib76) 2018; 3 Duensing, Duensing, Crum, Münger (bib52) 2001; 61 Khan, Davy, McIntosh, Jackson, Hinz, Wang, Doorbar (bib82) 2011; 85 Nakagawa, Huibregtse (bib105) 2000; 20 Roberts, Hillman, Knight, Gallimore (bib128) 2003; 77 Brand, Iida, Corrigan, Braverman, Coan, Flanigan, Stein, Salgia, Rolff, Kimple (bib19) 2017; 10 Martinez-Zapien, Ruiz, Poirson, Mitschler, Ramirez, Forster, Cousido-Siah, Masson, Pol, Podjarny (bib99) 2016; 529 Jones, Münger (bib77) 1996 Celegato, Messa, Bertagnin, Mercorelli, Loregian (bib26) 2021; 14 Adiga, Eswaran, Pandey, Sharan, Kabekkodu (bib1) 2021; 157 Toussaint-Smith, Donner, Roman (bib148) 2004; 23 Chabeda, Yanez, Lamprecht, Meyers, Rybicki, Hitzeroth (bib28) 2018; 5 Barrow-Laing, Chen, Roman (bib11) 2010; 400 Menges, Baglia, Lapoint, McCance (bib102) 2006; 66 Zhang, Dakic, Chen, Dai, Schlegel, Liu (bib171) 2017; 8 Kim, Kim, Kim, Suh, Chung, Song (bib83) 2013; 18 Shah, Anwar, Park, Jafri, Choi (bib134) 2015; 5 Disbrow, Sunitha, Baker, Hanover, Schlegel (bib49) 2003; 311 Zhang, B., Chen, W., Roman, A., 2006. The E7 proteins of low-and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proceedings of the National Academy of Sciences 103(2), 437–442. Bobdey, Sathwara, Jain, Balasubramaniam (bib17) 2016; 37 Grm, Massimi, Gammoh, Banks (bib64) 2005; 24 Oh, Kim, Choi, Cho, Oh, Choi, Jung, Song, Ahn, Kim (bib109) 2015; 6 Moon, Kohn, De Ferrari, Kaykas (bib104) 2004; 5 Akhatova, Chan, Azizan, Aimagambetova (bib3) 2021; 10 Castro-Muñoz, Manzo-Merino, Muñoz-Bello, Olmedo-Nieva, Cedro-Tanda, Alfaro-Ruiz, Hidalgo-Miranda, Madrid-Marina, Lizano (bib25) 2019; 9 Farley, Truong, Goo, Uyehara, Belnap, Larsen (bib54) 2006; 103 Rogel-Gaillard, Pehau-Arnaudet, Breitburd, Orth (bib130) 1993; 101 Huh, K.-W., DeMasi, J., Ogawa, H., Nakatani, Y., Howley, P.M., Münger, K., 2005. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proceedings of the National Academy of Sciences 102(32), 11492–11497. Brennan, Offiah, McSherry, Hopkins (bib22) 2009 Williams, Filippova, Soto, Duerksen-Hughes (bib163) 2011; 6 Rodon, Dienstmann, Serra, Tabernero (bib129) 2013; 10 Knight, Turnell, Roberts (bib87) 2006; 80 Arbyn, Weiderpass, Bruni, de Sanjosé, Saraiya, Ferlay, Bray (bib7) 2020; 8 Manzo-Merino, Contreras-Paredes, Vázquez-Ulloa, Rocha-Zavaleta, Fuentes-Gonzalez, Lizano (bib98) 2014; 45 Pertierra, Hughes, Vega, Olalla-Tárraga (bib118) 2017; 12 Chen, Lin, Tsao, Chen (bib33) 2004; 78 Wang, Meyers, Wang, Chow, Zheng (bib158) 2011; 85 Al Moustafa, Foulkes, Benlimame, Wong, Yen, Bergeron, Batist, Alpert, Alaoui-Jamali (bib5) 2004; 23 Nguyen, Song, Liem, Androphy, Liu, Lambert (bib107) 2002; 76 Hammes, Tekmal, Naud, Edelweiss, Kirma, Valente, Syrjänen, Cunha-Filho (bib68) 2007; 105 Galvão, Coimbra (bib57) 2020; 156 Zanier, ould M’hamed, Boulade-Ladame, Rybin, Chappelle, Atkinson, Kieffer, Travé, G (bib169) 2012; 20 Vieira, Leonard, White, Starrett, Temiz, Lorenz, Lee, Soares, Lambert, Howley (bib155) 2014; 5 Cheng, Chou, Hsu, Chen (bib34) 2012; 19 D’Abramo, Archambault (bib40) 2011; 5 Gewin, Myers, Kiyono, Galloway (bib60) 2004; 18 Li, Labrecque, Gauzzi, Cuddihy, Wong, Pellegrini, Matlashewski, Koromilas (bib92) 1999; 18 de Carvalho Galvão, Coimbra (bib41) 2020; 156 Zagouras, P., Stifani, S., Blaumueller, C.M., Carcangiu, M.L., Artavanis-Tsakonas, S., 1995. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proceedings of the National Academy of Sciences 92(14), 6414–6418. Bagarazzi, Yan, Morrow, Shen, Parker, Lee, Giffear, Pankhong, Khan, Broderick, Knott, Lin, Boyer, Draghia-Akli, White, Kim, Weiner, Sardesai (bib9) 2012; 4 Thomas, Laura, Hepner, Guccione, Sawyers, Lasky, Banks (bib145) 2002; 21 Graham (bib63) 2006 Baleja, Cherry, Liu, Gao, Nicklaus, Voigt, Chen, Androphy (bib10) 2006; 72 Hasan, Zannetti, Parroche, Goutagny, Malfroy, Roblot, Carreira, Hussain, Müller, Taylor-Papadimitriou (bib69) 2013; 210 White, Titolo, Brault, Thauvette, Pelletier, Welchner, Bourgon, Doyon, Ogilvie, Yoakim (bib162) 2003; 278 Yang, Jeang, Cheng, Cheng, Yang, Wu, Hung (bib166) 2016; 15 Wright, Nuñez, Doudna (bib164) 2016; 164 Reschner, Bontems, Le Gac, Lambermont, Marcélis, Defrancq, Hubert, Moucheron, Mesmaeker, Raes (bib126) 2013; 20 Cruz-Gregorio, Manzo-Merino, Gonzaléz-García, Pedraza-Chaverri, Medina-Campos, Valverde, Rojas, Rodríguez-Sastre, García-Cuellar, Lizano (bib39) 2018; 14 Paavonen (bib112) 2007; 11 Song, Ding, Ren, Sun, Yang, Wang, Feng, Liu, Wang (bib136) 2017; 38 Wang, Kennedy, Das, McIntosh, Howell, Isaacson, Hinz, Davy, Doorbar (bib156) 2009; 83 Henderson, Chakravarthy, Su, Boshoff, Fenton (bib70) 2014; 7 Warren, Westrich, Doorslaer, Pyeon (bib159) 2017; 9 Tian, Liu, Fan, Li, Cui, Jin, Huang, Xie, Li, Huang (bib146) 2022; 24 Varilla, Atienza, Dasanu (bib151) 2013; 13 Pal, Kundu (bib113) 2020; 10 Brehm, Nielsen, Miska, McCance, Reid, Bannister, Kouzarides (bib21) 1999; 18 Oetke, Auvinen, Pawlita, Alonso (bib108) 2000; 145 Phelps, Yee, Münger, Howley (bib119) 1988; 53 de Villiers, Fauquet, Broker, Bernard, HH (bib43) 2004; 324 Ganguly (bib58) 2012; 35 Pal, Kundu (bib114) 2020 Chojnacki, Melendy (bib36) 2018; 46 Chavez-Blanco, Perez-Sanchez, Gonzalez-Fierro, Vela-Chavez, Candelaria, Cetina, Vidal, Dueñas-Gonzalez (bib31) 2004; 4 Hinds, Mittnacht, Dulic, Arnold, Reed, Weinberg (bib71) 1992; 70 Rösl, Das, Lengert, Geletneky, Zur Hausen (bib131) 1997; 71 Veeraraghavalu, Subbaiah, Srivastava, Chakrabarti, Syal, Krishna (bib154) 2005; 79 Gupta, Mania-Pramanik (bib67) 2019; 26 Zwerschke, W., Mazurek, S., Massimi, P., Banks, L., Eigenbrodt, E., Jansen-Dürr, P., 1999. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proceedings of the National Academy of Sciences 96(4), 1291–1296. Sanchez-Perez, Soriano, Clarke, Gaston (bib132) 1997; 78 Wu, Chuang, Lin, Sung, Cheng, Lee (bib165) 2014; 35 Jung, Kato, Kim (bib78) 2013; 435 Asiaf, Ahmad, Mohammad, Zargar (bib8) 2014; 23 Filippova, Song, Connolly, Dermody, Duerksen-Hughes (bib56) 2002; 277 Lee, S.S., Weiss, R.S., Javier, R.T., 1997. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proceedings of the National Academy of Sciences 94(13), 6670–6675. Ren, Cheng, Lu, Yang (bib125) 2013; 49 Ghanbari, Gresley, Naughton, Kuhnert, Sirbu, Ashrafi, G.H (bib61) 2019; 9 Park, K., Atchison, M.L., 1991. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3'enhancer and the immunoglobulin heavy-chain mu E1 site. Proceedings of the National Academy of Sciences 88(21), 9804–9808. DeMasi, J., Huh, K.-W., Nakatani, Y., Münger, K., Howley, P.M., 2005. Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding. Proceedings of the National Academy of Sciences 102(32), 11486–11491. Razavi, Tajiknia, Majidi, Ghandali, Mirzaei, Rahimian, Hamblin, Mirzaei (bib123) 2021; 157 Dinneen, Ceresa (bib48) 2004; 5 Horner, DiMaio (bib72) 2007; 81 Zahra, Patel, Dey, Pandey, Mishra (bib168) 2021; 25 Be, Hong, Wei, Androphy, Chen, Baleja (bib13) 2001; 40 Deshpande, Raina, Shinde, Mansara, Karandikar, Kaul-Ghanekar (bib45) 2019; 143 Dhandapani, Mahesh, Brann (bib46) 2007; 102 Conrad, Bubb, Schlegel (bib37) 1993; 67 Richards, Doble, Wasson, Haider, Blair, Wittmann, Macdonald (bib127) 2014; 88 Kim, Juhnn, Kang, Park, Sung, Bang, Song (bib84) 2006; 63 Cardeal, Boccardo, Termini, Rabachini, Andreoli, di Loreto, Filho, Villa, Maria-Engler (bib24) 2012; 7 Ganti, Broniarczyk, Manoubi, Massimi, Mittal, Pim, Szalmas, Thatte, Thomas, Tomaić, Banks (bib59) 2015; 7 Tsao, Li, Tsai, Chen (bib150) 1996; 70 Guifen, Fachun, Enliang, Xiaomu, Xiuwen, Zhenshan (bib65) 2011; 38 Fani, Mahmoodi, Emadzadeh, Avan, Karimi, Ferns, Rezayi, Amiri (bib53) 2020; 44 McINTYRE, Frattini, Grossman, Laimins (bib101) 1993; 67 Tian, Liu, Fan, Li, Cui, Jin, Huang, Xie, Li, Huang, Hu, Zhou, Tian (bib147) 2022; 24 Branca, Ciotti, Santini, Di Bonito, Benedetto, Giorgi, Paba, Favalli, Costa, Agarossi (bib18) 2004; 122 Crook, Vousden, Tidy (bib38) 1991; 67 Ta 10.1016/j.critrevonc.2022.103675_bib175 10.1016/j.critrevonc.2022.103675_bib170 Duensing (10.1016/j.critrevonc.2022.103675_bib52) 2001; 61 Ramachandran (10.1016/j.critrevonc.2022.103675_bib120) 2012; 31 Veeraraghavalu (10.1016/j.critrevonc.2022.103675_bib154) 2005; 79 Wang (10.1016/j.critrevonc.2022.103675_bib158) 2011; 85 de Carvalho Galvão (10.1016/j.critrevonc.2022.103675_bib41) 2020; 156 Razavi (10.1016/j.critrevonc.2022.103675_bib122) 2021; 157 Doorbar (10.1016/j.critrevonc.2022.103675_bib50) 2013; 445 Cheng (10.1016/j.critrevonc.2022.103675_bib34) 2012; 19 Wang (10.1016/j.critrevonc.2022.103675_bib156) 2009; 83 White (10.1016/j.critrevonc.2022.103675_bib160) 2005; 49 Zhang (10.1016/j.critrevonc.2022.103675_bib171) 2017; 8 Hasan (10.1016/j.critrevonc.2022.103675_bib69) 2013; 210 Longworth (10.1016/j.critrevonc.2022.103675_bib95) 2004; 78 Menges (10.1016/j.critrevonc.2022.103675_bib102) 2006; 66 Tenaillon (10.1016/j.critrevonc.2022.103675_bib144) 2016; 536 Graham (10.1016/j.critrevonc.2022.103675_bib63) 2006 Hsu (10.1016/j.critrevonc.2022.103675_bib73) 2014; 157 Songock (10.1016/j.critrevonc.2022.103675_bib137) 2017; 231 Zheng (10.1016/j.critrevonc.2022.103675_bib172) 2002; 22 Pal (10.1016/j.critrevonc.2022.103675_bib114) 2020 Barrow-Laing (10.1016/j.critrevonc.2022.103675_bib11) 2010; 400 Bergvall (10.1016/j.critrevonc.2022.103675_bib15) 2013; 445 Sanchez-Perez (10.1016/j.critrevonc.2022.103675_bib132) 1997; 78 Zanier (10.1016/j.critrevonc.2022.103675_bib169) 2012; 20 Arany (10.1016/j.critrevonc.2022.103675_bib6) 2002; 55 Wright (10.1016/j.critrevonc.2022.103675_bib164) 2016; 164 Thomas (10.1016/j.critrevonc.2022.103675_bib145) 2002; 21 Ferlay (10.1016/j.critrevonc.2022.103675_bib55) 2019; 144 10.1016/j.critrevonc.2022.103675_bib167 Dinneen (10.1016/j.critrevonc.2022.103675_bib48) 2004; 5 10.1016/j.critrevonc.2022.103675_bib74 Nakagawa (10.1016/j.critrevonc.2022.103675_bib105) 2000; 20 Brehm (10.1016/j.critrevonc.2022.103675_bib21) 1999; 18 Cardeal (10.1016/j.critrevonc.2022.103675_bib24) 2012; 7 Akhatova (10.1016/j.critrevonc.2022.103675_bib3) 2021; 10 Kelley (10.1016/j.critrevonc.2022.103675_bib80) 2005; 79 Fani (10.1016/j.critrevonc.2022.103675_bib53) 2020; 44 Conrad (10.1016/j.critrevonc.2022.103675_bib37) 1993; 67 Dhandapani (10.1016/j.critrevonc.2022.103675_bib46) 2007; 102 Organization (10.1016/j.critrevonc.2022.103675_bib111) 2017; 35 Talora (10.1016/j.critrevonc.2022.103675_bib142) 2005; 305 Kabsch (10.1016/j.critrevonc.2022.103675_bib79) 2002; 76 Stöppler (10.1016/j.critrevonc.2022.103675_bib139) 1996; 223 Vats (10.1016/j.critrevonc.2022.103675_bib153) 2021; 11 Brennan (10.1016/j.critrevonc.2022.103675_bib22) 2009 Razavi (10.1016/j.critrevonc.2022.103675_bib123) 2021; 157 Kranjec (10.1016/j.critrevonc.2022.103675_bib88) 2016; 2 Shah (10.1016/j.critrevonc.2022.103675_bib134) 2015; 5 Jin (10.1016/j.critrevonc.2022.103675_bib76) 2018; 3 Richards (10.1016/j.critrevonc.2022.103675_bib127) 2014; 88 Zheng (10.1016/j.critrevonc.2022.103675_bib173) 2004; 3 D’Abramo (10.1016/j.critrevonc.2022.103675_bib40) 2011; 5 Khan (10.1016/j.critrevonc.2022.103675_bib82) 2011; 85 Gupta (10.1016/j.critrevonc.2022.103675_bib67) 2019; 26 Yang (10.1016/j.critrevonc.2022.103675_bib166) 2016; 15 Varilla (10.1016/j.critrevonc.2022.103675_bib151) 2013; 13 Chaturvedi (10.1016/j.critrevonc.2022.103675_bib30) 2010; 46 Mandal (10.1016/j.critrevonc.2022.103675_bib97) 2016; 1 Lee (10.1016/j.critrevonc.2022.103675_bib89) 2022 Rogel-Gaillard (10.1016/j.critrevonc.2022.103675_bib130) 1993; 101 10.1016/j.critrevonc.2022.103675_bib62 Cherry (10.1016/j.critrevonc.2022.103675_bib35) 2013; 8 Asiaf (10.1016/j.critrevonc.2022.103675_bib8) 2014; 23 Brand (10.1016/j.critrevonc.2022.103675_bib19) 2017; 10 Bobdey (10.1016/j.critrevonc.2022.103675_bib17) 2016; 37 Berg (10.1016/j.critrevonc.2022.103675_bib14) 1997; 71 Akhatova (10.1016/j.critrevonc.2022.103675_bib4) 2021; 10 Charette (10.1016/j.critrevonc.2022.103675_bib29) 2007; 26 Ren (10.1016/j.critrevonc.2022.103675_bib125) 2013; 49 Stevanović (10.1016/j.critrevonc.2022.103675_bib138) 2015; 33 Adiga (10.1016/j.critrevonc.2022.103675_bib1) 2021; 157 Gupta (10.1016/j.critrevonc.2022.103675_bib66) 2018; 42 Ghanbari (10.1016/j.critrevonc.2022.103675_bib61) 2019; 9 Kim (10.1016/j.critrevonc.2022.103675_bib85) 2009; 30 Galvão (10.1016/j.critrevonc.2022.103675_bib57) 2020; 156 Deshpande (10.1016/j.critrevonc.2022.103675_bib45) 2019; 143 DiMaio (10.1016/j.critrevonc.2022.103675_bib47) 2013; 445 Branca (10.1016/j.critrevonc.2022.103675_bib18) 2004; 122 Kim (10.1016/j.critrevonc.2022.103675_bib84) 2006; 63 Pappa (10.1016/j.critrevonc.2022.103675_bib115) 2018; 39 Zahra (10.1016/j.critrevonc.2022.103675_bib168) 2021; 25 Li (10.1016/j.critrevonc.2022.103675_bib92) 1999; 18 Be (10.1016/j.critrevonc.2022.103675_bib13) 2001; 40 Kim (10.1016/j.critrevonc.2022.103675_bib86) 2003; 10 Roberts (10.1016/j.critrevonc.2022.103675_bib128) 2003; 77 Bray (10.1016/j.critrevonc.2022.103675_bib20) 2018; 68 Martinez-Zapien (10.1016/j.critrevonc.2022.103675_bib99) 2016; 529 Vieira (10.1016/j.critrevonc.2022.103675_bib155) 2014; 5 Nguyen (10.1016/j.critrevonc.2022.103675_bib107) 2002; 76 Liu (10.1016/j.critrevonc.2022.103675_bib94) 2006; 281 Tian (10.1016/j.critrevonc.2022.103675_bib147) 2022; 24 Kennedy (10.1016/j.critrevonc.2022.103675_bib81) 2014; 88 Chen (10.1016/j.critrevonc.2022.103675_bib33) 2004; 78 Al Moustafa (10.1016/j.critrevonc.2022.103675_bib5) 2004; 23 Patel (10.1016/j.critrevonc.2022.103675_bib117) 1999; 18 Ganti (10.1016/j.critrevonc.2022.103675_bib59) 2015; 7 Cruz-Gregorio (10.1016/j.critrevonc.2022.103675_bib39) 2018; 14 Reschner (10.1016/j.critrevonc.2022.103675_bib126) 2013; 20 Makarova (10.1016/j.critrevonc.2022.103675_bib96) 2015; 13 Castro-Muñoz (10.1016/j.critrevonc.2022.103675_bib25) 2019; 9 Serrano (10.1016/j.critrevonc.2022.103675_bib133) 2018; 47 Phelps (10.1016/j.critrevonc.2022.103675_bib119) 1988; 53 Ivashkiv (10.1016/j.critrevonc.2022.103675_bib75) 2014; 14 Network (10.1016/j.critrevonc.2022.103675_bib106) 2017; 543 Gewin (10.1016/j.critrevonc.2022.103675_bib60) 2004; 18 Pal (10.1016/j.critrevonc.2022.103675_bib113) 2020; 10 Grm (10.1016/j.critrevonc.2022.103675_bib64) 2005; 24 Pertierra (10.1016/j.critrevonc.2022.103675_bib118) 2017; 12 10.1016/j.critrevonc.2022.103675_bib44 Ganguly (10.1016/j.critrevonc.2022.103675_bib58) 2012; 35 Wu (10.1016/j.critrevonc.2022.103675_bib165) 2014; 35 Suprynowicz (10.1016/j.critrevonc.2022.103675_bib141) 2008; 27 Arbyn (10.1016/j.critrevonc.2022.103675_bib7) 2020; 8 Williams (10.1016/j.critrevonc.2022.103675_bib163) 2011; 6 Farley (10.1016/j.critrevonc.2022.103675_bib54) 2006; 103 Trimble (10.1016/j.critrevonc.2022.103675_bib149) 2015; 386 Warren (10.1016/j.critrevonc.2022.103675_bib159) 2017; 9 Bharti (10.1016/j.critrevonc.2022.103675_bib16) 2018; 10 Burley (10.1016/j.critrevonc.2022.103675_bib23) 2020 de Villiers (10.1016/j.critrevonc.2022.103675_bib43) 2004; 324 Tian (10.1016/j.critrevonc.2022.103675_bib146) 2022; 24 Chojnacki (10.1016/j.critrevonc.2022.103675_bib36) 2018; 46 Disbrow (10.1016/j.critrevonc.2022.103675_bib49) 2003; 311 Rodon (10.1016/j.critrevonc.2022.103675_bib129) 2013; 10 Celegato (10.1016/j.critrevonc.2022.103675_bib26) 2021; 14 Crook (10.1016/j.critrevonc.2022.103675_bib38) 1991; 67 Hinds (10.1016/j.critrevonc.2022.103675_bib71) 1992; 70 Paavonen (10.1016/j.critrevonc.2022.103675_bib112) 2007; 11 Jones (10.1016/j.critrevonc.2022.103675_bib77) 1996 Oh (10.1016/j.critrevonc.2022.103675_bib109) 2015; 6 Vats (10.1016/j.critrevonc.2022.103675_bib152) 2022 10.1016/j.critrevonc.2022.103675_bib32 Manzo-Merino (10.1016/j.critrevonc.2022.103675_bib98) 2014; 45 Celegato (10.1016/j.critrevonc.2022.103675_bib27) 2022; 14 Jung (10.1016/j.critrevonc.2022.103675_bib78) 2013; 435 Oetke (10.1016/j.critrevonc.2022.103675_bib108) 2000; 145 Baleja (10.1016/j.critrevonc.2022.103675_bib10) 2006; 72 Zur (10.1016/j.critrevonc.2022.103675_bib174) 2002; 2 10.1016/j.critrevonc.2022.103675_bib116 Henderson (10.1016/j.critrevonc.2022.103675_bib70) 2014; 7 Kim (10.1016/j.critrevonc.2022.103675_bib83) 2013; 18 White (10.1016/j.critrevonc.2022.103675_bib161) 2001; 276 DOORBAR (10.1016/j.critrevonc.2022.103675_bib51) 1996; 218 White (10.1016/j.critrevonc.2022.103675_bib162) 2003; 278 Filippova (10.1016/j.critrevonc.2022.103675_bib56) 2002; 277 Chabeda (10.1016/j.critrevonc.2022.103675_bib28) 2018; 5 Guifen (10.1016/j.critrevonc.2022.103675_bib65) 2011; 38 Rangarajan (10.1016/j.critrevonc.2022.103675_bib121) 2001; 286 Leechanachai (10.1016/j.critrevonc.2022.103675_bib91) 1992; 7 Tsao (10.1016/j.critrevonc.2022.103675_bib150) 1996; 70 Chavez-Blanco (10.1016/j.critrevonc.2022.103675_bib31) 2004; 4 McIntosh (10.1016/j.critrevonc.2022.103675_bib100) 2010; 123 Toussaint-Smith (10.1016/j.critrevonc.2022.103675_bib148) 2004; 23 Liu (10.1016/j.critrevonc.2022.103675_bib93) 2016; 23 Wang (10.1016/j.critrevonc.2022.103675_bib157) 2010; 291 Sun (10.1016/j.critrevonc.2022.103675_bib140) 2014; 10 De Nola (10.1016/j.critrevonc.2022.103675_bib42) 2021; 162 Regan (10.1016/j.critrevonc.2022.103675_bib124) 2008; 82 Ojesina (10.1016/j.critrevonc.2022.103675_bib110) 2014; 506 Sima (10.1016/j.critrevonc.2022.103675_bib135) 2008; 13 Bagarazzi (10.1016/j.critrevonc.2022.103675_bib9) 2012; 4 Knight (10.1016/j.critrevonc.2022.103675_bib87) 2006; 80 Moody (10.1016/j.critrevonc.2022.103675_bib103) 2010; 10 Talora (10.1016/j.critrevonc.2022.103675_bib143) 2002; 16 10.1016/j.critrevonc.2022.103675_bib90 Moon (10.1016/j.critrevonc.2022.103675_bib104) 2004; 5 Akagi (10.1016/j.critrevonc.2022.103675_bib2) 2014; 24 Horner (10.1016/j.critrevonc.2022.103675_bib72) 2007; 81 Song (10.1016/j.critrevonc.2022.103675_bib136) 2017; 38 Bauknecht (10.1016/j.critrevonc.2022.103675_bib12) 1998; 72 Hammes (10.1016/j.critrevonc.2022.103675_bib68) 2007; 105 McINTYRE (10.1016/j.critrevonc.2022.103675_bib101) 1993; 67 Rösl (10.1016/j.critrevonc.2022.103675_bib131) 1997; 71
References_xml	– volume: 16 start-page: 2252 year: 2002 end-page: 2263 ident: bib143 article-title: Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation publication-title: Genes Dev. – volume: 7 year: 2012 ident: bib24 article-title: HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis publication-title: PLoS One – volume: 18 start-page: 5061 year: 1999 end-page: 5072 ident: bib117 article-title: The E6 protein of human papillomavirus type 16 binds to and inhibits co‐activation by CBP and p300 publication-title: EMBO J. – volume: 144 start-page: 1941 year: 2019 end-page: 1953 ident: bib55 article-title: Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods publication-title: Int. J. Cancer – volume: 14 start-page: 21 year: 2018 ident: bib39 article-title: Human papillomavirus types 16 and 18 early-expressed proteins differentially modulate the cellular redox state and DNA damage publication-title: Int. J. Biol. Sci. – volume: 105 start-page: 157 year: 2007 end-page: 165 ident: bib68 article-title: Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression—clinicopathological correlation publication-title: Gynecol. Oncol. – volume: 157 start-page: 1262 year: 2014 end-page: 1278 ident: bib73 article-title: Development and applications of CRISPR-Cas9 for genome engineering publication-title: Cell – volume: 26 start-page: 7386 year: 2007 end-page: 7390 ident: bib29 article-title: The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Akt-dependent manner publication-title: Oncogene – reference: Lee, S.S., Weiss, R.S., Javier, R.T., 1997. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proceedings of the National Academy of Sciences 94(13), 6670–6675. – volume: 157 year: 2021 ident: bib1 article-title: Molecular landscape of recurrent cervical cancer publication-title: Crit. Rev. Oncol. Hematol. – volume: 18 start-page: 2269 year: 2004 end-page: 2282 ident: bib60 article-title: Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex publication-title: Genes Dev. – volume: 122 start-page: 902 year: 2004 end-page: 911 ident: bib18 article-title: Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer publication-title: Am. J. Clin. Pathol. – volume: 24 start-page: 171 year: 2022 end-page: 179 ident: bib146 article-title: Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells publication-title: Mol. Ther. Oncol. – volume: 14 start-page: 193 year: 2022 ident: bib27 article-title: Targeted disruption of E6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against HPV-transformed cancer cells publication-title: Cancers – volume: 101 start-page: 843 year: 1993 end-page: 851 ident: bib130 article-title: Cytopathic effect in human papillomavirus type 1–Induced inclusion warts: In vitro analysis of the contribution of two forms of the viral E4 protein publication-title: J. invest. Dermatol. – volume: 78 start-page: 1333 year: 2004 end-page: 1343 ident: bib33 article-title: Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice publication-title: J. Virol. – volume: 445 start-page: 80 year: 2013 end-page: 98 ident: bib50 article-title: The E4 protein; structure, function and patterns of expression publication-title: Virology – volume: 35 start-page: 5753 year: 2017 end-page: 5755 ident: bib111 article-title: Human papillomavirus vaccines: WHO position paper, May 2017–Recommendations publication-title: Vaccine – volume: 35 start-page: 67 year: 2012 end-page: 76 ident: bib58 article-title: Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value publication-title: Cell. Oncol. – volume: 20 start-page: 604 year: 2012 end-page: 617 ident: bib169 article-title: Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53 publication-title: Structure – volume: 88 start-page: 4173 year: 2014 end-page: 4179 ident: bib127 article-title: Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes publication-title: J. Virol. – volume: 4 start-page: 1 year: 2004 end-page: 6 ident: bib31 article-title: HER2 expression in cervical cancer as a potential therapeutic target publication-title: BMC Cancer – volume: 10 year: 2017 ident: bib19 article-title: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor publication-title: Sci. Signal. – volume: 20 start-page: 8244 year: 2000 end-page: 8253 ident: bib105 article-title: Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase publication-title: Mol. Cell. Biol. – volume: 31 start-page: 2725 year: 2012 end-page: 2737 ident: bib120 article-title: Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo publication-title: Oncogene – volume: 9 start-page: 233 year: 2017 ident: bib159 article-title: Roles of APOBEC3A and APOBEC3B in human papillomavirus infection and disease progression publication-title: Viruses – volume: 67 start-page: 547 year: 1991 end-page: 556 ident: bib38 article-title: Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation publication-title: Cell – volume: 278 start-page: 26765 year: 2003 end-page: 26772 ident: bib162 article-title: Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction publication-title: J. Biol. Chem. – volume: 11 year: 2021 ident: bib153 article-title: Human Papillomavirus E6 and E7: what remains? publication-title: Tumour Virus Res. – volume: 71 start-page: 3853 year: 1997 end-page: 3863 ident: bib14 article-title: Functional interactions between papillomavirus E1 and E2 proteins publication-title: J. Virol. – volume: 79 start-page: 3737 year: 2005 end-page: 3747 ident: bib80 article-title: The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase publication-title: J. Virol. – volume: 5 start-page: e02234 year: 2014 end-page: 02214 ident: bib155 article-title: Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B publication-title: MBio – volume: 276 start-page: 22426 year: 2001 end-page: 22438 ident: bib161 article-title: Characterization of recombinant HPV6 and 11 E1 helicases: effect of ATP on the interaction of E1 with E2 and mapping of a minimal helicase domain publication-title: J. Biol. Chem. – volume: 223 start-page: 251 year: 1996 end-page: 254 ident: bib139 article-title: The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA publication-title: Virology – volume: 67 start-page: 6170 year: 1993 end-page: 6178 ident: bib37 article-title: The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein publication-title: J. Virol. – volume: 70 start-page: 993 year: 1992 end-page: 1006 ident: bib71 article-title: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins publication-title: Cell – volume: 6 start-page: 36219 year: 2015 ident: bib109 article-title: HER2 as a novel therapeutic target for cervical cancer publication-title: Oncotarget – volume: 277 start-page: 21730 year: 2002 end-page: 21739 ident: bib56 article-title: The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis publication-title: J. Biol.BChem. – volume: 76 start-page: 13039 year: 2002 end-page: 13048 ident: bib107 article-title: A mutant of human papillomavirus type 16 E6 deficient in binding α-helix partners displays reduced oncogenic potential in vivo publication-title: J. Virol. – reference: Park, K., Atchison, M.L., 1991. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3'enhancer and the immunoglobulin heavy-chain mu E1 site. Proceedings of the National Academy of Sciences 88(21), 9804–9808. – volume: 286 start-page: 23 year: 2001 end-page: 30 ident: bib121 article-title: Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt publication-title: Virology – volume: 435 start-page: 339 year: 2013 end-page: 344 ident: bib78 article-title: A novel function of HPV16-E6/E7 in epithelial–mesenchymal transition publication-title: Biochem. Biophys. Res. Commun. – volume: 23 start-page: 109 year: 2016 ident: bib93 article-title: ERK signaling pathway is involved in HPV-16 E6 but not E7 oncoprotein-induced HIF-1α protein accumulation in NSCLC cells publication-title: Oncol. Res. – volume: 55 start-page: 331 year: 2002 end-page: 339 ident: bib6 article-title: Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5′-segment of the upstream regulatory region (URR) publication-title: Antiviral Res. – volume: 13 start-page: 722 year: 2015 end-page: 736 ident: bib96 article-title: An updated evolutionary classification of CRISPR-Cas systems publication-title: Nat. Rev. Microbiol. – volume: 9 start-page: 1 year: 2019 end-page: 11 ident: bib61 article-title: Biological activities of Ficus carica latex for potential therapeutics in Human Papillomavirus (HPV) related cervical cancers publication-title: Sci. Rep. – volume: 24 start-page: 171 year: 2022 end-page: 179 ident: bib147 article-title: Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells publication-title: Mol. Ther. Oncol. – volume: 102 start-page: 522 year: 2007 end-page: 538 ident: bib46 article-title: Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP‐1 and NFκB transcription factors publication-title: J. Neurochem. – volume: 39 start-page: 1547 year: 2018 end-page: 1554 ident: bib115 article-title: Novel structural approaches concerning HPV proteins: Insight into targeted therapies for cervical cancer publication-title: Oncol. Rep. – volume: 72 start-page: 2113 year: 1998 end-page: 2124 ident: bib12 article-title: Overexpression of C/EBPβ represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein publication-title: J. Virol. – volume: 80 start-page: 7416 year: 2006 end-page: 7426 ident: bib87 article-title: Role for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins publication-title: J. Virol. – volume: 529 start-page: 541 year: 2016 end-page: 545 ident: bib99 article-title: Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53 publication-title: Nature – start-page: Jvi0150321 year: 2022 ident: bib152 article-title: Loss of the E6AP ubiquitin ligase induces p53-dependent phosphorylation of HPV-18 E6 in cells derived from cervical cancer publication-title: J. Virol. – reference: Goodwin, E.C., DiMaio, D., 2000. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proceedings of the National Academy of Sciences 97(23), 12513–12518. – volume: 311 start-page: 105 year: 2003 end-page: 114 ident: bib49 article-title: Codon optimization of the HPV-16 E5 gene enhances protein expression publication-title: Virology – volume: 2 start-page: 342 year: 2002 end-page: 350 ident: bib174 article-title: Papillomaviruses and cancer: from basic studies to clinical application publication-title: Nature reviews cancer – volume: 2 start-page: 70 year: 2016 end-page: 77 ident: bib88 article-title: The high-risk HPV E6 target scribble (hScrib) is required for HPV E6 expression in cervical tumour-derived cell lines publication-title: Papillomavirus Res. – volume: 10 start-page: 53 year: 2021 ident: bib4 article-title: The efficacy of therapeutic DNA vaccines expressing the human papillomavirus E6 and E7 oncoproteins for treatment of cervical publication-title: Cancer System. Rev. Vaccines – volume: 67 start-page: 3142 year: 1993 end-page: 3150 ident: bib101 article-title: Human papillomavirus type 18 E7 protein requires intact Cys-XX-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding publication-title: J. Virol. – volume: 5 start-page: 691 year: 2004 end-page: 701 ident: bib104 article-title: WNT and β-catenin signalling: diseases and therapies publication-title: Nat. Rev. Gen. – volume: 13 start-page: 273 year: 2008 end-page: 281 ident: bib135 article-title: RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53 publication-title: Apoptosis – volume: 231 start-page: 56 year: 2017 end-page: 75 ident: bib137 article-title: The human papillomavirus E7 oncoprotein as a regulator of transcription publication-title: Virus Res. – volume: 445 start-page: 99 year: 2013 end-page: 114 ident: bib47 article-title: The E5 proteins publication-title: Virology – volume: 26 start-page: 1 year: 2019 end-page: 19 ident: bib67 article-title: RETRACTED ARTICLE: molecular mechanisms in progression of HPV-associated cervical carcinogenesis publication-title: J. Biomed. Sci. – volume: 11 start-page: S3 year: 2007 end-page: S9 ident: bib112 article-title: Human papillomavirus infection and the development of cervical cancer and related genital neoplasias publication-title: Int. J. Infect. Dis. – volume: 77 start-page: 673 year: 2003 end-page: 684 ident: bib128 article-title: The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts publication-title: J. Virol. – volume: 218 start-page: 114 year: 1996 end-page: 126 ident: bib51 article-title: Analysis of HPV1 E4 complexes and their association with keratinsin vivo publication-title: Virology – volume: 78 start-page: 3009 year: 1997 end-page: 3018 ident: bib132 article-title: Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis publication-title: J. Gen. Virol. – volume: 4 start-page: 155ra138 year: 2012 ident: bib9 article-title: Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses publication-title: Sci. Translat. Med. – volume: 10 start-page: 707 year: 2003 end-page: 716 ident: bib86 article-title: E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes publication-title: Cancer Gene Ther. – volume: 8 year: 2013 ident: bib35 article-title: Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function publication-title: PLoS One – volume: 123 start-page: 2810 year: 2010 end-page: 2822 ident: bib100 article-title: E1^ E4-mediated keratin phosphorylation and ubiquitylation: A mechanism for keratin depletion in HPV16-infected epithelium publication-title: J. Cell Sci. – volume: 21 start-page: 5088 year: 2002 end-page: 5096 ident: bib145 article-title: Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation publication-title: Oncogene – volume: 37 start-page: 278 year: 2016 ident: bib17 article-title: Burden of cervical cancer and role of screening in India. Indian journal of medical and paediatric oncology: official journal of Indian Society of Medical & Paediatric publication-title: Oncology – volume: 45 start-page: 525 year: 2014 end-page: 539 ident: bib98 article-title: The role of signaling pathways in cervical cancer and molecular therapeutic targets publication-title: Arch. Med. Res. – volume: 53 start-page: 539 year: 1988 end-page: 547 ident: bib119 article-title: The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A publication-title: Cell – volume: 7 start-page: 19 year: 1992 ident: bib91 article-title: The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus publication-title: Oncogene – volume: 143 year: 2019 ident: bib45 article-title: Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer publication-title: Prostaglandins Other Lipid Med. – volume: 281 start-page: 578 year: 2006 end-page: 586 ident: bib94 article-title: Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor publication-title: J. Biol. Chem. – volume: 70 start-page: 7535 year: 1996 end-page: 7539 ident: bib150 article-title: Human papillomavirus type 11 and 16 E5 represses p21 (WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes publication-title: J. Virol. – volume: 5 start-page: 46 year: 2018 end-page: 58 ident: bib28 article-title: Therapeutic vaccines for high-risk HPV-associated diseases publication-title: Papillomavirus Res. – volume: 5 start-page: 80 year: 2011 ident: bib40 article-title: Small molecule inhibitors of human papillomavirus protein-protein interactions publication-title: Open Virol. J. – volume: 103 start-page: 425 year: 2006 end-page: 430 ident: bib54 article-title: A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia publication-title: Gynecol. Oncol. – volume: 156 year: 2020 ident: bib41 article-title: Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: new molecular targets, current prospects publication-title: Crit. Rev. Oncol. Hematol. – volume: 25 year: 2021 ident: bib168 article-title: A study of oxidative stress in cervical cancer-an institutional study publication-title: Biochem. Biophys. Rep. – volume: 19 start-page: 580 year: 2012 end-page: 586 ident: bib34 article-title: Influence of HPV16 E6/7 on the expression of FGF2 and FGFR type B in cervical carcinogenesis publication-title: Reprod. Sci. – volume: 400 start-page: 233 year: 2010 end-page: 239 ident: bib11 article-title: Low- and high-risk human papillomavirus E7 proteins regulate p130 differently publication-title: Virology – volume: 72 start-page: 49 year: 2006 end-page: 59 ident: bib10 article-title: Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins publication-title: Antiviral Res. – volume: 68 start-page: 394 year: 2018 end-page: 424 ident: bib20 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. – volume: 76 start-page: 12162 year: 2002 end-page: 12172 ident: bib79 article-title: The human papillomavirus type 16 E5 protein impairs TRAIL-and FasL-mediated apoptosis in HaCaT cells by different mechanisms publication-title: J. Virol. – volume: 23 start-page: 350 year: 2004 end-page: 358 ident: bib5 article-title: E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells publication-title: Oncogene – volume: 145 start-page: 2183 year: 2000 end-page: 2191 ident: bib108 article-title: Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation publication-title: Arch. Virol. – volume: 305 start-page: 343 year: 2005 end-page: 354 ident: bib142 article-title: Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways publication-title: Exp. Cell Res. – volume: 156 year: 2020 ident: bib57 article-title: Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: new molecular targets, current prospects publication-title: Crit. Rev. Oncol. Hematol. – volume: 88 start-page: 11965 year: 2014 end-page: 11972 ident: bib81 article-title: Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease publication-title: J. Virol. – volume: 30 start-page: 753 year: 2009 end-page: 757 ident: bib85 article-title: Involvement of NF-κB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein publication-title: Carcinogenesis – volume: 40 start-page: 1293 year: 2001 end-page: 1299 ident: bib13 article-title: Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP publication-title: Biochemistry – volume: 506 start-page: 371 year: 2014 end-page: 375 ident: bib110 article-title: Landscape of genomic alterations in cervical carcinomas publication-title: Nature – volume: 210 start-page: 1369 year: 2013 end-page: 1387 ident: bib69 article-title: The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter publication-title: J. Exp. Med. – volume: 7 start-page: 1833 year: 2014 end-page: 1841 ident: bib70 article-title: APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development publication-title: Cell Rep. – volume: 82 start-page: 10042 year: 2008 end-page: 10051 ident: bib124 article-title: Bap31 is a novel target of the human papillomavirus E5 protein publication-title: J. Virol. – volume: 291 start-page: 67 year: 2010 end-page: 75 ident: bib157 article-title: Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo publication-title: Cancer Lett. – volume: 35 start-page: 1823 year: 2014 end-page: 1829 ident: bib165 article-title: Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting publication-title: Carcinogenesis – volume: 61 start-page: 2356 year: 2001 end-page: 2360 ident: bib52 article-title: Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype publication-title: Cancer Re. – volume: 23 start-page: 206 year: 2014 end-page: 224 ident: bib8 article-title: Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection publication-title: Eur. J. Cancer Prevent. – volume: 38 start-page: 4469 year: 2011 end-page: 4474 ident: bib65 article-title: Effects of chromium picolinate supplementation on the growth, carcass quality and gene expression of beef during the finishing period publication-title: Mol. Biol. Rep. – start-page: 159 year: 2020 end-page: 171 ident: bib23 article-title: Epigenetic regulation of human papillomavirus transcription in the productive virus life cycle publication-title: Seminars in Immunopathology – volume: 386 start-page: 2078 year: 2015 end-page: 2088 ident: bib149 article-title: Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial publication-title: Lancet – volume: 18 start-page: 2449 year: 1999 end-page: 2458 ident: bib21 article-title: The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth publication-title: EMBO J. – volume: 22 start-page: 496 year: 2002 end-page: 498 ident: bib172 article-title: Effects of anti-HPV16 E6-ribozyme on the proliferation and apoptosis of human cervical cancer cell line CaSKi publication-title: Di 1 Jun Yi Da Xue Xue Bao Acad. J. First Med. Coll. of PLA – volume: 3 year: 2018 ident: bib76 article-title: Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model publication-title: JCI insight – volume: 14 start-page: 193 year: 2021 ident: bib26 article-title: Targeted disruption of E6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against HPV-transformed cancer cells publication-title: Cancers – volume: 162 year: 2021 ident: bib42 article-title: Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications publication-title: Crit. Rev. Oncol. Hematol. – volume: 78 start-page: 3533 year: 2004 end-page: 3541 ident: bib95 article-title: The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31 publication-title: J. Virol. – volume: 10 start-page: 550 year: 2010 end-page: 560 ident: bib103 article-title: Human papillomavirus oncoproteins: pathways to transformation publication-title: Nat. Rev. Cancer – volume: 44 year: 2020 ident: bib53 article-title: Correlation of human papillomavirus 16 and 18 with cervical cancer and their diagnosis methods in Iranian women: a systematic review and meta-analysis publication-title: Curr. Problems Cancer – volume: 164 start-page: 29 year: 2016 end-page: 44 ident: bib164 article-title: Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering publication-title: Cell – volume: 12 year: 2017 ident: bib118 article-title: High resolution spatial mapping of human footprint across Antarctica and its implications for the strategic conservation of avifauna publication-title: PLoS one – volume: 6 start-page: 45 year: 2011 end-page: 57 ident: bib163 article-title: HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress publication-title: Future Virol. – reference: Zwerschke, W., Mazurek, S., Massimi, P., Banks, L., Eigenbrodt, E., Jansen-Dürr, P., 1999. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proceedings of the National Academy of Sciences 96(4), 1291–1296. – volume: 157 year: 2021 ident: bib122 article-title: Gynecologic cancers and non-coding RNAs: epigenetic regulators with emerging roles publication-title: Crit. Rev. Oncol. Hematol. – volume: 71 start-page: 362 year: 1997 end-page: 370 ident: bib131 article-title: Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription publication-title: J. Virol. – reference: Huh, K.-W., DeMasi, J., Ogawa, H., Nakatani, Y., Howley, P.M., Münger, K., 2005. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proceedings of the National Academy of Sciences 102(32), 11492–11497. – reference: Zagouras, P., Stifani, S., Blaumueller, C.M., Carcangiu, M.L., Artavanis-Tsakonas, S., 1995. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proceedings of the National Academy of Sciences 92(14), 6414–6418. – volume: 543 start-page: 378 year: 2017 ident: bib106 article-title: Integrated genomic and molecular characterization of cervical cancer publication-title: Nature – volume: 9 start-page: 1 year: 2019 end-page: 13 ident: bib25 article-title: The Human Papillomavirus (HPV) E1 protein regulates the expression of cellular genes involved in immune response publication-title: Sci. Rep. – volume: 18 start-page: 123 year: 2013 ident: bib83 article-title: Cyclooxygenase-1 and-2: molecular targets for cervical neoplasia publication-title: J. Cancer Prevent. – volume: 24 start-page: 5149 year: 2005 end-page: 5164 ident: bib64 article-title: Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein publication-title: Oncogene – volume: 24 start-page: 185 year: 2014 end-page: 199 ident: bib2 article-title: Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability publication-title: Genome Res. – volume: 23 start-page: 2988 year: 2004 end-page: 2995 ident: bib148 article-title: Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors publication-title: Oncogene – volume: 3 start-page: 1129 year: 2004 end-page: 1134 ident: bib173 article-title: Ribozyme targeting HPV16 E6E7 transcripts in cervical cancer cells suppresses cell growth and sensitizes cells to chemotherapy and radiotherapy publication-title: Cancer biology & therapy – volume: 66 start-page: 5555 year: 2006 end-page: 5559 ident: bib102 article-title: Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein publication-title: Cancer Res. – reference: DeMasi, J., Huh, K.-W., Nakatani, Y., Münger, K., Howley, P.M., 2005. Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding. Proceedings of the National Academy of Sciences 102(32), 11486–11491. – volume: 63 start-page: 930 year: 2006 end-page: 938 ident: bib84 article-title: Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1, 2 and PI3K/Akt publication-title: Cell. Mol. Life Sci. CMLS – volume: 10 year: 2014 ident: bib140 article-title: Expression of suppressor of cytokine signaling 1 (SOCS1) impairs viral clearance and exacerbates lung injury during influenza infection publication-title: PLoS Pathogens – volume: 13 start-page: 1241 year: 2013 end-page: 1256 ident: bib151 article-title: Immune alterations and immunotherapy prospects in head and neck cancer publication-title: Expert Opin. Biol. Ther. – volume: 33 start-page: 1543 year: 2015 ident: bib138 article-title: Complete regression of metastatic cervical cancer after treatment with human papillomavirus–targeted tumor-infiltrating T cells publication-title: J. Clin. Oncol. – volume: 20 start-page: 435 year: 2013 end-page: 443 ident: bib126 article-title: Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53 publication-title: Gene Ther. – volume: 1 year: 2016 ident: bib97 article-title: The head and neck cancer immune landscape and its immunotherapeutic implications publication-title: JCI Insight – volume: 10 start-page: 15 year: 2018 end-page: 73 ident: bib16 article-title: Therapeutic startegies for human papillomavirus infection and associated cancers publication-title: Front. Biosci.) – start-page: 327 year: 1996 end-page: 337 ident: bib77 article-title: Interactions of the human papillomavirus E7 protein with cell cycle regulators publication-title: Seminars in Cancer Biology – volume: 536 start-page: 165 year: 2016 end-page: 170 ident: bib144 article-title: Tempo and mode of genome evolution in a 50,000-generation experiment publication-title: Nature – volume: 157 year: 2021 ident: bib123 article-title: Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles publication-title: Crit. Rev. Oncol. Hematol. – volume: 7 start-page: 3530 year: 2015 end-page: 3551 ident: bib59 article-title: The human papillomavirus E6 PDZ binding motif: from life cycle to malignancy publication-title: Viruses – volume: 85 start-page: 9984 year: 2011 end-page: 9997 ident: bib82 article-title: Role of calpain in the formation of human papillomavirus type 16 E1^ E4 amyloid fibers and reorganization of the keratin network publication-title: J. Virol – start-page: 3116 year: 2020 ident: bib114 article-title: Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy publication-title: Front. Microbiol. – volume: 18 start-page: 5727 year: 1999 end-page: 5737 ident: bib92 article-title: The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α publication-title: Oncogene – volume: 49 start-page: 4834 year: 2005 end-page: 4842 ident: bib160 article-title: Biphenylsulfonacetic acid inhibitors of the human papillomavirus type 6 E1 helicase inhibit ATP hydrolysis by an allosteric mechanism involving tyrosine 486 publication-title: Antimicrob. Agents Chemother. – volume: 324 start-page: 17 year: 2004 end-page: 27 ident: bib43 article-title: Classification of papillomaviruses publication-title: Virology – volume: 81 start-page: 6254 year: 2007 end-page: 6264 ident: bib72 article-title: The DNA binding domain of a papillomavirus E2 protein programs a chimeric nuclease to cleave integrated human papillomavirus DNA in HeLa cervical carcinoma cells publication-title: J. Virol. – volume: 14 start-page: 36 year: 2014 end-page: 49 ident: bib75 article-title: Regulation of type I interferon responses publication-title: Nat. Rev. Immunol. – volume: 10 start-page: 3116 year: 2020 ident: bib113 article-title: Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy publication-title: Front. Microbiol. – start-page: 2010 year: 2009 ident: bib22 article-title: Tight junctions: a barrier to the initiation and progression of breast cancer? publication-title: J. Biomed. Biotechnol. – volume: 46 start-page: 229 year: 2018 end-page: 241 ident: bib36 article-title: The human papillomavirus DNA helicase E1 binds, stimulates, and confers processivity to cellular DNA polymerase epsilon publication-title: Nucl. Acids Res. – volume: 27 start-page: 1071 year: 2008 end-page: 1078 ident: bib141 article-title: HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells publication-title: Oncogene – volume: 42 start-page: 161 year: 2018 end-page: 174 ident: bib66 article-title: HPV: molecular pathways and targets publication-title: Curr. Problems Cancer – volume: 8 start-page: e191 year: 2020 end-page: e203 ident: bib7 article-title: Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis publication-title: Lancet Glob. Health – volume: 5 start-page: 1 year: 2015 end-page: 14 ident: bib134 article-title: In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response publication-title: Sci. Rep. – volume: 46 start-page: S20 year: 2010 end-page: S26 ident: bib30 article-title: Beyond cervical cancer: burden of other HPV-related cancers among men and women publication-title: J. Adol. Health – year: 2022 ident: bib89 article-title: Structural and biochemical analysis of the PTPN4 PDZ domain bound to the C-terminal tail of the human papillomavirus E6 oncoprotein publication-title: J. Microbiol. – reference: Chellappan, S., Kraus, V.B., Kroger, B., Munger, K., Howley, P.M., Phelps, W., Nevins, J., 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proceedings of the National Academy of Sciences 89(10), 4549–4553. – start-page: 193 year: 2006 end-page: 211 ident: bib63 article-title: Late events in the life cycle of human papillomaviruses publication-title: Papillomavirus Res. Nat. History Vaccines Beyond – volume: 83 start-page: 3668 year: 2009 end-page: 3683 ident: bib156 article-title: Phosphorylation of the human papillomavirus type 16 E1^ E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability publication-title: J. Virol. – volume: 15 start-page: 989 year: 2016 end-page: 1007 ident: bib166 article-title: Current state in the development of candidate therapeutic HPV vaccines publication-title: Exp. Rev. Vaccines – reference: Zhang, B., Chen, W., Roman, A., 2006. The E7 proteins of low-and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proceedings of the National Academy of Sciences 103(2), 437–442. – volume: 38 start-page: 1246 year: 2017 end-page: 1251 ident: bib136 article-title: Effects of Src on cervical cancer cells proliferation and apoptosis through ERK signal transduction pathway publication-title: Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi – volume: 5 start-page: 606 year: 2004 end-page: 615 ident: bib48 article-title: Continual expression of rab5 (Q79L) causes a ligand‐independent EGFR internalization and diminishes EGFR activity publication-title: Traffic – volume: 10 year: 2021 ident: bib3 article-title: The efficacy of therapeutic DNA vaccines expressing the human papillomavirus E6 and E7 oncoproteins for treatment of cervical publication-title: Cancer System. Rev. Vaccines – volume: 10 start-page: 143 year: 2013 end-page: 153 ident: bib129 article-title: Development of PI3K inhibitors: lessons learned from early clinical trials. Nature reviews publication-title: Clin. Oncol. – volume: 85 start-page: 8080 year: 2011 end-page: 8092 ident: bib158 article-title: Construction of a full transcription map of human papillomavirus type 18 during productive viral infection publication-title: J. Virol. – volume: 445 start-page: 35 year: 2013 end-page: 56 ident: bib15 article-title: The E1 proteins publication-title: Virology – volume: 47 start-page: 14 year: 2018 end-page: 26 ident: bib133 article-title: Epidemiology and burden of HPV-related disease publication-title: Best Pract. Res. Clin. Obs. Gynaecol. – volume: 8 start-page: 96323 year: 2017 ident: bib171 article-title: Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation publication-title: Oncotarget – volume: 49 start-page: 3889 year: 2013 end-page: 3899 ident: bib125 article-title: Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment publication-title: Eur. J. Cancer – volume: 79 start-page: 7889 year: 2005 end-page: 7898 ident: bib154 article-title: Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1; Su (H); Lag-1 activation publication-title: J. Virol. – volume: 4 start-page: 1 issue: 1 year: 2004 ident: 10.1016/j.critrevonc.2022.103675_bib31 article-title: HER2 expression in cervical cancer as a potential therapeutic target publication-title: BMC Cancer doi: 10.1186/1471-2407-4-59 – volume: 16 start-page: 2252 issue: 17 year: 2002 ident: 10.1016/j.critrevonc.2022.103675_bib143 article-title: Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation publication-title: Genes Dev. doi: 10.1101/gad.988902 – start-page: 2010 year: 2009 ident: 10.1016/j.critrevonc.2022.103675_bib22 article-title: Tight junctions: a barrier to the initiation and progression of breast cancer? publication-title: J. Biomed. Biotechnol. – volume: 76 start-page: 12162 issue: 23 year: 2002 ident: 10.1016/j.critrevonc.2022.103675_bib79 article-title: The human papillomavirus type 16 E5 protein impairs TRAIL-and FasL-mediated apoptosis in HaCaT cells by different mechanisms publication-title: J. Virol. doi: 10.1128/JVI.76.23.12162-12172.2002 – volume: 14 start-page: 193 issue: 1 year: 2022 ident: 10.1016/j.critrevonc.2022.103675_bib27 article-title: Targeted disruption of E6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against HPV-transformed cancer cells publication-title: Cancers doi: 10.3390/cancers14010193 – volume: 400 start-page: 233 issue: 2 year: 2010 ident: 10.1016/j.critrevonc.2022.103675_bib11 article-title: Low- and high-risk human papillomavirus E7 proteins regulate p130 differently publication-title: Virology doi: 10.1016/j.virol.2010.01.034 – volume: 10 start-page: 550 issue: 8 year: 2010 ident: 10.1016/j.critrevonc.2022.103675_bib103 article-title: Human papillomavirus oncoproteins: pathways to transformation publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2886 – volume: 123 start-page: 2810 issue: 16 year: 2010 ident: 10.1016/j.critrevonc.2022.103675_bib100 article-title: E1^ E4-mediated keratin phosphorylation and ubiquitylation: A mechanism for keratin depletion in HPV16-infected epithelium publication-title: J. Cell Sci. doi: 10.1242/jcs.061978 – volume: 45 start-page: 525 issue: 7 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib98 article-title: The role of signaling pathways in cervical cancer and molecular therapeutic targets publication-title: Arch. Med. Res. doi: 10.1016/j.arcmed.2014.10.008 – volume: 101 start-page: 843 issue: 6 year: 1993 ident: 10.1016/j.critrevonc.2022.103675_bib130 article-title: Cytopathic effect in human papillomavirus type 1–Induced inclusion warts: In vitro analysis of the contribution of two forms of the viral E4 protein publication-title: J. invest. Dermatol. doi: 10.1111/1523-1747.ep12371705 – volume: 231 start-page: 56 year: 2017 ident: 10.1016/j.critrevonc.2022.103675_bib137 article-title: The human papillomavirus E7 oncoprotein as a regulator of transcription publication-title: Virus Res. doi: 10.1016/j.virusres.2016.10.017 – volume: 11 year: 2021 ident: 10.1016/j.critrevonc.2022.103675_bib153 article-title: Human Papillomavirus E6 and E7: what remains? publication-title: Tumour Virus Res. doi: 10.1016/j.tvr.2021.200213 – volume: 83 start-page: 3668 issue: 8 year: 2009 ident: 10.1016/j.critrevonc.2022.103675_bib156 article-title: Phosphorylation of the human papillomavirus type 16 E1^ E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability publication-title: J. Virol. doi: 10.1128/JVI.02063-08 – volume: 8 start-page: e191 issue: 2 year: 2020 ident: 10.1016/j.critrevonc.2022.103675_bib7 article-title: Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(19)30482-6 – volume: 281 start-page: 578 issue: 1 year: 2006 ident: 10.1016/j.critrevonc.2022.103675_bib94 article-title: Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor publication-title: J. Biol. Chem. doi: 10.1074/jbc.M508455200 – volume: 445 start-page: 35 issue: 1–2 year: 2013 ident: 10.1016/j.critrevonc.2022.103675_bib15 article-title: The E1 proteins publication-title: Virology doi: 10.1016/j.virol.2013.07.020 – volume: 72 start-page: 2113 issue: 3 year: 1998 ident: 10.1016/j.critrevonc.2022.103675_bib12 article-title: Overexpression of C/EBPβ represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein publication-title: J. Virol. doi: 10.1128/JVI.72.3.2113-2124.1998 – volume: 12 issue: 1 year: 2017 ident: 10.1016/j.critrevonc.2022.103675_bib118 article-title: High resolution spatial mapping of human footprint across Antarctica and its implications for the strategic conservation of avifauna publication-title: PLoS one doi: 10.1371/journal.pone.0168280 – volume: 70 start-page: 7535 issue: 11 year: 1996 ident: 10.1016/j.critrevonc.2022.103675_bib150 article-title: Human papillomavirus type 11 and 16 E5 represses p21 (WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes publication-title: J. Virol. doi: 10.1128/jvi.70.11.7535-7539.1996 – volume: 291 start-page: 67 issue: 1 year: 2010 ident: 10.1016/j.critrevonc.2022.103675_bib157 article-title: Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo publication-title: Cancer Lett. doi: 10.1016/j.canlet.2009.09.022 – volume: 23 start-page: 2988 issue: 17 year: 2004 ident: 10.1016/j.critrevonc.2022.103675_bib148 article-title: Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors publication-title: Oncogene doi: 10.1038/sj.onc.1207442 – volume: 71 start-page: 3853 issue: 5 year: 1997 ident: 10.1016/j.critrevonc.2022.103675_bib14 article-title: Functional interactions between papillomavirus E1 and E2 proteins publication-title: J. Virol. doi: 10.1128/jvi.71.5.3853-3863.1997 – start-page: 193 year: 2006 ident: 10.1016/j.critrevonc.2022.103675_bib63 article-title: Late events in the life cycle of human papillomaviruses publication-title: Papillomavirus Res. Nat. History Vaccines Beyond – volume: 85 start-page: 9984 issue: 19 year: 2011 ident: 10.1016/j.critrevonc.2022.103675_bib82 article-title: Role of calpain in the formation of human papillomavirus type 16 E1^ E4 amyloid fibers and reorganization of the keratin network publication-title: J. Virol doi: 10.1128/JVI.02158-10 – volume: 76 start-page: 13039 issue: 24 year: 2002 ident: 10.1016/j.critrevonc.2022.103675_bib107 article-title: A mutant of human papillomavirus type 16 E6 deficient in binding α-helix partners displays reduced oncogenic potential in vivo publication-title: J. Virol. doi: 10.1128/JVI.76.24.13039-13048.2002 – volume: 324 start-page: 17 year: 2004 ident: 10.1016/j.critrevonc.2022.103675_bib43 article-title: Classification of papillomaviruses publication-title: Virology doi: 10.1016/j.virol.2004.03.033 – volume: 33 start-page: 1543 issue: 14 year: 2015 ident: 10.1016/j.critrevonc.2022.103675_bib138 article-title: Complete regression of metastatic cervical cancer after treatment with human papillomavirus–targeted tumor-infiltrating T cells publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2014.58.9093 – volume: 11 start-page: S3 year: 2007 ident: 10.1016/j.critrevonc.2022.103675_bib112 article-title: Human papillomavirus infection and the development of cervical cancer and related genital neoplasias publication-title: Int. J. Infect. Dis. doi: 10.1016/S1201-9712(07)60015-0 – volume: 79 start-page: 3737 issue: 6 year: 2005 ident: 10.1016/j.critrevonc.2022.103675_bib80 article-title: The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase publication-title: J. Virol. doi: 10.1128/JVI.79.6.3737-3747.2005 – volume: 19 start-page: 580 issue: 6 year: 2012 ident: 10.1016/j.critrevonc.2022.103675_bib34 article-title: Influence of HPV16 E6/7 on the expression of FGF2 and FGFR type B in cervical carcinogenesis publication-title: Reprod. Sci. doi: 10.1177/1933719111432874 – volume: 10 issue: 1 year: 2021 ident: 10.1016/j.critrevonc.2022.103675_bib3 article-title: The efficacy of therapeutic DNA vaccines expressing the human papillomavirus E6 and E7 oncoproteins for treatment of cervical publication-title: Cancer System. Rev. Vaccines – volume: 18 start-page: 2269 issue: 18 year: 2004 ident: 10.1016/j.critrevonc.2022.103675_bib60 article-title: Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex publication-title: Genes Dev. doi: 10.1101/gad.1214704 – volume: 24 start-page: 171 year: 2022 ident: 10.1016/j.critrevonc.2022.103675_bib146 article-title: Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells publication-title: Mol. Ther. Oncol. doi: 10.1016/j.omto.2021.12.011 – volume: 22 start-page: 496 issue: 6 year: 2002 ident: 10.1016/j.critrevonc.2022.103675_bib172 article-title: Effects of anti-HPV16 E6-ribozyme on the proliferation and apoptosis of human cervical cancer cell line CaSKi publication-title: Di 1 Jun Yi Da Xue Xue Bao Acad. J. First Med. Coll. of PLA – volume: 35 start-page: 5753 issue: 43 year: 2017 ident: 10.1016/j.critrevonc.2022.103675_bib111 article-title: Human papillomavirus vaccines: WHO position paper, May 2017–Recommendations publication-title: Vaccine doi: 10.1016/j.vaccine.2017.05.069 – volume: 23 start-page: 109 issue: 3 year: 2016 ident: 10.1016/j.critrevonc.2022.103675_bib93 article-title: ERK signaling pathway is involved in HPV-16 E6 but not E7 oncoprotein-induced HIF-1α protein accumulation in NSCLC cells publication-title: Oncol. Res. doi: 10.3727/096504015X14496932933610 – volume: 38 start-page: 1246 issue: 9 year: 2017 ident: 10.1016/j.critrevonc.2022.103675_bib136 article-title: Effects of Src on cervical cancer cells proliferation and apoptosis through ERK signal transduction pathway publication-title: Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi – volume: 18 start-page: 123 issue: 2 year: 2013 ident: 10.1016/j.critrevonc.2022.103675_bib83 article-title: Cyclooxygenase-1 and-2: molecular targets for cervical neoplasia publication-title: J. Cancer Prevent. – volume: 35 start-page: 67 issue: 2 year: 2012 ident: 10.1016/j.critrevonc.2022.103675_bib58 article-title: Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value publication-title: Cell. Oncol. doi: 10.1007/s13402-011-0069-x – volume: 13 start-page: 722 issue: 11 year: 2015 ident: 10.1016/j.critrevonc.2022.103675_bib96 article-title: An updated evolutionary classification of CRISPR-Cas systems publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro3569 – volume: 85 start-page: 8080 issue: 16 year: 2011 ident: 10.1016/j.critrevonc.2022.103675_bib158 article-title: Construction of a full transcription map of human papillomavirus type 18 during productive viral infection publication-title: J. Virol. doi: 10.1128/JVI.00670-11 – volume: 162 year: 2021 ident: 10.1016/j.critrevonc.2022.103675_bib42 article-title: Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2021.103343 – volume: 63 start-page: 930 issue: 7 year: 2006 ident: 10.1016/j.critrevonc.2022.103675_bib84 article-title: Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1, 2 and PI3K/Akt publication-title: Cell. Mol. Life Sci. CMLS doi: 10.1007/s00018-005-5561-x – volume: 49 start-page: 3889 issue: 18 year: 2013 ident: 10.1016/j.critrevonc.2022.103675_bib125 article-title: Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2013.07.140 – volume: 24 start-page: 5149 issue: 33 year: 2005 ident: 10.1016/j.critrevonc.2022.103675_bib64 article-title: Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein publication-title: Oncogene doi: 10.1038/sj.onc.1208701 – volume: 38 start-page: 4469 issue: 7 year: 2011 ident: 10.1016/j.critrevonc.2022.103675_bib65 article-title: Effects of chromium picolinate supplementation on the growth, carcass quality and gene expression of beef during the finishing period publication-title: Mol. Biol. Rep. doi: 10.1007/s11033-010-0576-2 – volume: 1 issue: 17 year: 2016 ident: 10.1016/j.critrevonc.2022.103675_bib97 article-title: The head and neck cancer immune landscape and its immunotherapeutic implications publication-title: JCI Insight doi: 10.1172/jci.insight.89829 – volume: 8 issue: 12 year: 2013 ident: 10.1016/j.critrevonc.2022.103675_bib35 article-title: Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function publication-title: PLoS One doi: 10.1371/journal.pone.0084506 – volume: 157 year: 2021 ident: 10.1016/j.critrevonc.2022.103675_bib1 article-title: Molecular landscape of recurrent cervical cancer publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2020.103178 – volume: 7 start-page: 3530 issue: 7 year: 2015 ident: 10.1016/j.critrevonc.2022.103675_bib59 article-title: The human papillomavirus E6 PDZ binding motif: from life cycle to malignancy publication-title: Viruses doi: 10.3390/v7072785 – volume: 10 start-page: 15 issue: 1 year: 2018 ident: 10.1016/j.critrevonc.2022.103675_bib16 article-title: Therapeutic startegies for human papillomavirus infection and associated cancers publication-title: Front. Biosci.) doi: 10.2741/e808 – volume: 66 start-page: 5555 issue: 11 year: 2006 ident: 10.1016/j.critrevonc.2022.103675_bib102 article-title: Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-0499 – volume: 78 start-page: 3533 issue: 7 year: 2004 ident: 10.1016/j.critrevonc.2022.103675_bib95 article-title: The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31 publication-title: J. Virol. doi: 10.1128/JVI.78.7.3533-3541.2004 – volume: 506 start-page: 371 issue: 7488 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib110 article-title: Landscape of genomic alterations in cervical carcinomas publication-title: Nature doi: 10.1038/nature12881 – volume: 71 start-page: 362 issue: 1 year: 1997 ident: 10.1016/j.critrevonc.2022.103675_bib131 article-title: Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription publication-title: J. Virol. doi: 10.1128/jvi.71.1.362-370.1997 – volume: 529 start-page: 541 issue: 7587 year: 2016 ident: 10.1016/j.critrevonc.2022.103675_bib99 article-title: Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53 publication-title: Nature doi: 10.1038/nature16481 – ident: 10.1016/j.critrevonc.2022.103675_bib116 doi: 10.1073/pnas.88.21.9804 – volume: 386 start-page: 2078 issue: 10008 year: 2015 ident: 10.1016/j.critrevonc.2022.103675_bib149 article-title: Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial publication-title: Lancet doi: 10.1016/S0140-6736(15)00239-1 – volume: 21 start-page: 5088 issue: 33 year: 2002 ident: 10.1016/j.critrevonc.2022.103675_bib145 article-title: Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation publication-title: Oncogene doi: 10.1038/sj.onc.1205668 – ident: 10.1016/j.critrevonc.2022.103675_bib74 doi: 10.1073/pnas.0505337102 – volume: 46 start-page: S20 issue: 4 year: 2010 ident: 10.1016/j.critrevonc.2022.103675_bib30 article-title: Beyond cervical cancer: burden of other HPV-related cancers among men and women publication-title: J. Adol. Health doi: 10.1016/j.jadohealth.2010.01.016 – volume: 4 start-page: 155ra138 issue: 155 year: 2012 ident: 10.1016/j.critrevonc.2022.103675_bib9 article-title: Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses publication-title: Sci. Translat. Med. doi: 10.1126/scitranslmed.3004414 – volume: 67 start-page: 3142 issue: 6 year: 1993 ident: 10.1016/j.critrevonc.2022.103675_bib101 article-title: Human papillomavirus type 18 E7 protein requires intact Cys-XX-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding publication-title: J. Virol. doi: 10.1128/jvi.67.6.3142-3150.1993 – volume: 18 start-page: 2449 issue: 9 year: 1999 ident: 10.1016/j.critrevonc.2022.103675_bib21 article-title: The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth publication-title: EMBO J. doi: 10.1093/emboj/18.9.2449 – volume: 31 start-page: 2725 issue: 22 year: 2012 ident: 10.1016/j.critrevonc.2022.103675_bib120 article-title: Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo publication-title: Oncogene doi: 10.1038/onc.2011.455 – volume: 223 start-page: 251 issue: 1 year: 1996 ident: 10.1016/j.critrevonc.2022.103675_bib139 article-title: The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA publication-title: Virology doi: 10.1006/viro.1996.0475 – volume: 18 start-page: 5727 issue: 42 year: 1999 ident: 10.1016/j.critrevonc.2022.103675_bib92 article-title: The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α publication-title: Oncogene doi: 10.1038/sj.onc.1202960 – ident: 10.1016/j.critrevonc.2022.103675_bib167 doi: 10.1073/pnas.92.14.6414 – volume: 156 year: 2020 ident: 10.1016/j.critrevonc.2022.103675_bib57 article-title: Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: new molecular targets, current prospects publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2020.103111 – volume: 27 start-page: 1071 issue: 8 year: 2008 ident: 10.1016/j.critrevonc.2022.103675_bib141 article-title: HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells publication-title: Oncogene doi: 10.1038/sj.onc.1210725 – volume: 61 start-page: 2356 issue: 6 year: 2001 ident: 10.1016/j.critrevonc.2022.103675_bib52 article-title: Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype publication-title: Cancer Re. – volume: 37 start-page: 278 issue: 4 year: 2016 ident: 10.1016/j.critrevonc.2022.103675_bib17 article-title: Burden of cervical cancer and role of screening in India. Indian journal of medical and paediatric oncology: official journal of Indian Society of Medical & Paediatric publication-title: Oncology – volume: 13 start-page: 1241 issue: 9 year: 2013 ident: 10.1016/j.critrevonc.2022.103675_bib151 article-title: Immune alterations and immunotherapy prospects in head and neck cancer publication-title: Expert Opin. Biol. Ther. doi: 10.1517/14712598.2013.810716 – volume: 5 start-page: 606 issue: 8 year: 2004 ident: 10.1016/j.critrevonc.2022.103675_bib48 article-title: Continual expression of rab5 (Q79L) causes a ligand‐independent EGFR internalization and diminishes EGFR activity publication-title: Traffic doi: 10.1111/j.1398-9219.2004.00204.x – volume: 10 issue: 460 year: 2017 ident: 10.1016/j.critrevonc.2022.103675_bib19 article-title: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor publication-title: Sci. Signal. doi: 10.1126/scisignal.aag1064 – volume: 3 issue: 8 year: 2018 ident: 10.1016/j.critrevonc.2022.103675_bib76 article-title: Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model publication-title: JCI insight doi: 10.1172/jci.insight.99488 – volume: 156 year: 2020 ident: 10.1016/j.critrevonc.2022.103675_bib41 article-title: Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: new molecular targets, current prospects publication-title: Crit. Rev. Oncol. Hematol. – volume: 7 start-page: 1833 issue: 6 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib70 article-title: APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.05.012 – volume: 6 start-page: 36219 issue: 34 year: 2015 ident: 10.1016/j.critrevonc.2022.103675_bib109 article-title: HER2 as a novel therapeutic target for cervical cancer publication-title: Oncotarget doi: 10.18632/oncotarget.5283 – volume: 53 start-page: 539 issue: 4 year: 1988 ident: 10.1016/j.critrevonc.2022.103675_bib119 article-title: The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A publication-title: Cell doi: 10.1016/0092-8674(88)90570-3 – volume: 105 start-page: 157 issue: 1 year: 2007 ident: 10.1016/j.critrevonc.2022.103675_bib68 article-title: Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression—clinicopathological correlation publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2006.11.023 – volume: 49 start-page: 4834 issue: 12 year: 2005 ident: 10.1016/j.critrevonc.2022.103675_bib160 article-title: Biphenylsulfonacetic acid inhibitors of the human papillomavirus type 6 E1 helicase inhibit ATP hydrolysis by an allosteric mechanism involving tyrosine 486 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.49.12.4834-4842.2005 – volume: 7 start-page: 19 issue: 1 year: 1992 ident: 10.1016/j.critrevonc.2022.103675_bib91 article-title: The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus publication-title: Oncogene – volume: 543 start-page: 378 issue: 7645 year: 2017 ident: 10.1016/j.critrevonc.2022.103675_bib106 article-title: Integrated genomic and molecular characterization of cervical cancer publication-title: Nature doi: 10.1038/nature21386 – volume: 9 start-page: 233 issue: 8 year: 2017 ident: 10.1016/j.critrevonc.2022.103675_bib159 article-title: Roles of APOBEC3A and APOBEC3B in human papillomavirus infection and disease progression publication-title: Viruses doi: 10.3390/v9080233 – volume: 445 start-page: 80 issue: 1–2 year: 2013 ident: 10.1016/j.critrevonc.2022.103675_bib50 article-title: The E4 protein; structure, function and patterns of expression publication-title: Virology doi: 10.1016/j.virol.2013.07.008 – volume: 103 start-page: 425 issue: 2 year: 2006 ident: 10.1016/j.critrevonc.2022.103675_bib54 article-title: A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2006.03.036 – volume: 305 start-page: 343 issue: 2 year: 2005 ident: 10.1016/j.critrevonc.2022.103675_bib142 article-title: Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2005.01.015 – volume: 72 start-page: 49 issue: 1 year: 2006 ident: 10.1016/j.critrevonc.2022.103675_bib10 article-title: Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins publication-title: Antiviral Res. doi: 10.1016/j.antiviral.2006.03.014 – volume: 5 start-page: 1 issue: 1 year: 2015 ident: 10.1016/j.critrevonc.2022.103675_bib134 article-title: In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response publication-title: Sci. Rep. doi: 10.1038/srep13446 – ident: 10.1016/j.critrevonc.2022.103675_bib90 doi: 10.1073/pnas.94.13.6670 – volume: 311 start-page: 105 issue: 1 year: 2003 ident: 10.1016/j.critrevonc.2022.103675_bib49 article-title: Codon optimization of the HPV-16 E5 gene enhances protein expression publication-title: Virology doi: 10.1016/S0042-6822(03)00129-6 – volume: 35 start-page: 1823 issue: 8 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib165 article-title: Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting publication-title: Carcinogenesis doi: 10.1093/carcin/bgu102 – volume: 42 start-page: 161 issue: 2 year: 2018 ident: 10.1016/j.critrevonc.2022.103675_bib66 article-title: HPV: molecular pathways and targets publication-title: Curr. Problems Cancer doi: 10.1016/j.currproblcancer.2018.03.003 – volume: 9 start-page: 1 issue: 1 year: 2019 ident: 10.1016/j.critrevonc.2022.103675_bib61 article-title: Biological activities of Ficus carica latex for potential therapeutics in Human Papillomavirus (HPV) related cervical cancers publication-title: Sci. Rep. doi: 10.1038/s41598-018-37665-6 – volume: 67 start-page: 6170 issue: 10 year: 1993 ident: 10.1016/j.critrevonc.2022.103675_bib37 article-title: The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein publication-title: J. Virol. doi: 10.1128/jvi.67.10.6170-6178.1993 – start-page: 3116 year: 2020 ident: 10.1016/j.critrevonc.2022.103675_bib114 article-title: Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy publication-title: Front. Microbiol. doi: 10.3389/fmicb.2019.03116 – ident: 10.1016/j.critrevonc.2022.103675_bib32 doi: 10.1073/pnas.89.10.4549 – volume: 5 start-page: 80 year: 2011 ident: 10.1016/j.critrevonc.2022.103675_bib40 article-title: Small molecule inhibitors of human papillomavirus protein-protein interactions publication-title: Open Virol. J. doi: 10.2174/1874357901105010080 – start-page: 327 year: 1996 ident: 10.1016/j.critrevonc.2022.103675_bib77 article-title: Interactions of the human papillomavirus E7 protein with cell cycle regulators – volume: 435 start-page: 339 issue: 3 year: 2013 ident: 10.1016/j.critrevonc.2022.103675_bib78 article-title: A novel function of HPV16-E6/E7 in epithelial–mesenchymal transition publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2013.04.060 – ident: 10.1016/j.critrevonc.2022.103675_bib175 doi: 10.1073/pnas.96.4.1291 – volume: 23 start-page: 206 issue: 3 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib8 article-title: Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection publication-title: Eur. J. Cancer Prevent. doi: 10.1097/CEJ.0b013e328364f273 – volume: 88 start-page: 11965 issue: 20 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib81 article-title: Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease publication-title: J. Virol. doi: 10.1128/JVI.01879-14 – volume: 5 start-page: 691 issue: 9 year: 2004 ident: 10.1016/j.critrevonc.2022.103675_bib104 article-title: WNT and β-catenin signalling: diseases and therapies publication-title: Nat. Rev. Gen. doi: 10.1038/nrg1427 – volume: 47 start-page: 14 year: 2018 ident: 10.1016/j.critrevonc.2022.103675_bib133 article-title: Epidemiology and burden of HPV-related disease publication-title: Best Pract. Res. Clin. Obs. Gynaecol. doi: 10.1016/j.bpobgyn.2017.08.006 – volume: 78 start-page: 1333 issue: 3 year: 2004 ident: 10.1016/j.critrevonc.2022.103675_bib33 article-title: Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice publication-title: J. Virol. doi: 10.1128/JVI.78.3.1333-1343.2004 – start-page: 159 year: 2020 ident: 10.1016/j.critrevonc.2022.103675_bib23 article-title: Epigenetic regulation of human papillomavirus transcription in the productive virus life cycle – volume: 3 start-page: 1129 issue: 11 year: 2004 ident: 10.1016/j.critrevonc.2022.103675_bib173 article-title: Ribozyme targeting HPV16 E6E7 transcripts in cervical cancer cells suppresses cell growth and sensitizes cells to chemotherapy and radiotherapy publication-title: Cancer biology & therapy doi: 10.4161/cbt.3.11.1215 – volume: 445 start-page: 99 issue: 1–2 year: 2013 ident: 10.1016/j.critrevonc.2022.103675_bib47 article-title: The E5 proteins publication-title: Virology doi: 10.1016/j.virol.2013.05.006 – volume: 67 start-page: 547 issue: 3 year: 1991 ident: 10.1016/j.critrevonc.2022.103675_bib38 article-title: Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation publication-title: Cell doi: 10.1016/0092-8674(91)90529-8 – volume: 18 start-page: 5061 issue: 18 year: 1999 ident: 10.1016/j.critrevonc.2022.103675_bib117 article-title: The E6 protein of human papillomavirus type 16 binds to and inhibits co‐activation by CBP and p300 publication-title: EMBO J. doi: 10.1093/emboj/18.18.5061 – volume: 81 start-page: 6254 issue: 12 year: 2007 ident: 10.1016/j.critrevonc.2022.103675_bib72 article-title: The DNA binding domain of a papillomavirus E2 protein programs a chimeric nuclease to cleave integrated human papillomavirus DNA in HeLa cervical carcinoma cells publication-title: J. Virol. doi: 10.1128/JVI.00232-07 – volume: 82 start-page: 10042 issue: 20 year: 2008 ident: 10.1016/j.critrevonc.2022.103675_bib124 article-title: Bap31 is a novel target of the human papillomavirus E5 protein publication-title: J. Virol. doi: 10.1128/JVI.01240-08 – volume: 40 start-page: 1293 issue: 5 year: 2001 ident: 10.1016/j.critrevonc.2022.103675_bib13 article-title: Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP publication-title: Biochemistry doi: 10.1021/bi0019592 – volume: 80 start-page: 7416 issue: 15 year: 2006 ident: 10.1016/j.critrevonc.2022.103675_bib87 article-title: Role for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins publication-title: J. Virol. doi: 10.1128/JVI.00196-06 – volume: 44 issue: 1 year: 2020 ident: 10.1016/j.critrevonc.2022.103675_bib53 article-title: Correlation of human papillomavirus 16 and 18 with cervical cancer and their diagnosis methods in Iranian women: a systematic review and meta-analysis publication-title: Curr. Problems Cancer doi: 10.1016/j.currproblcancer.2019.06.008 – volume: 276 start-page: 22426 issue: 25 year: 2001 ident: 10.1016/j.critrevonc.2022.103675_bib161 article-title: Characterization of recombinant HPV6 and 11 E1 helicases: effect of ATP on the interaction of E1 with E2 and mapping of a minimal helicase domain publication-title: J. Biol. Chem. doi: 10.1074/jbc.M101932200 – volume: 10 start-page: 707 issue: 9 year: 2003 ident: 10.1016/j.critrevonc.2022.103675_bib86 article-title: E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes publication-title: Cancer Gene Ther. doi: 10.1038/sj.cgt.7700623 – volume: 157 year: 2021 ident: 10.1016/j.critrevonc.2022.103675_bib122 article-title: Gynecologic cancers and non-coding RNAs: epigenetic regulators with emerging roles publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2020.103192 – volume: 164 start-page: 29 issue: 1–2 year: 2016 ident: 10.1016/j.critrevonc.2022.103675_bib164 article-title: Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering publication-title: Cell doi: 10.1016/j.cell.2015.12.035 – volume: 13 start-page: 273 issue: 2 year: 2008 ident: 10.1016/j.critrevonc.2022.103675_bib135 article-title: RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53 publication-title: Apoptosis doi: 10.1007/s10495-007-0163-8 – ident: 10.1016/j.critrevonc.2022.103675_bib170 doi: 10.1073/pnas.0510012103 – volume: 70 start-page: 993 issue: 6 year: 1992 ident: 10.1016/j.critrevonc.2022.103675_bib71 article-title: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins publication-title: Cell doi: 10.1016/0092-8674(92)90249-C – volume: 25 year: 2021 ident: 10.1016/j.critrevonc.2022.103675_bib168 article-title: A study of oxidative stress in cervical cancer-an institutional study publication-title: Biochem. Biophys. Rep. – volume: 26 start-page: 1 issue: 1 year: 2019 ident: 10.1016/j.critrevonc.2022.103675_bib67 article-title: RETRACTED ARTICLE: molecular mechanisms in progression of HPV-associated cervical carcinogenesis publication-title: J. Biomed. Sci. – volume: 24 start-page: 185 issue: 2 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib2 article-title: Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability publication-title: Genome Res. doi: 10.1101/gr.164806.113 – volume: 2 start-page: 70 year: 2016 ident: 10.1016/j.critrevonc.2022.103675_bib88 article-title: The high-risk HPV E6 target scribble (hScrib) is required for HPV E6 expression in cervical tumour-derived cell lines publication-title: Papillomavirus Res. doi: 10.1016/j.pvr.2016.04.001 – volume: 55 start-page: 331 issue: 2 year: 2002 ident: 10.1016/j.critrevonc.2022.103675_bib6 article-title: Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5′-segment of the upstream regulatory region (URR) publication-title: Antiviral Res. doi: 10.1016/S0166-3542(02)00070-0 – volume: 68 start-page: 394 issue: 6 year: 2018 ident: 10.1016/j.critrevonc.2022.103675_bib20 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. – volume: 536 start-page: 165 issue: 7615 year: 2016 ident: 10.1016/j.critrevonc.2022.103675_bib144 article-title: Tempo and mode of genome evolution in a 50,000-generation experiment publication-title: Nature doi: 10.1038/nature18959 – start-page: Jvi0150321 year: 2022 ident: 10.1016/j.critrevonc.2022.103675_bib152 article-title: Loss of the E6AP ubiquitin ligase induces p53-dependent phosphorylation of HPV-18 E6 in cells derived from cervical cancer publication-title: J. Virol. doi: 10.1128/jvi.01503-21 – volume: 5 start-page: 46 year: 2018 ident: 10.1016/j.critrevonc.2022.103675_bib28 article-title: Therapeutic vaccines for high-risk HPV-associated diseases publication-title: Papillomavirus Res. doi: 10.1016/j.pvr.2017.12.006 – volume: 210 start-page: 1369 issue: 7 year: 2013 ident: 10.1016/j.critrevonc.2022.103675_bib69 article-title: The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter publication-title: J. Exp. Med. doi: 10.1084/jem.20122394 – volume: 2 start-page: 342 issue: 5 year: 2002 ident: 10.1016/j.critrevonc.2022.103675_bib174 article-title: Papillomaviruses and cancer: from basic studies to clinical application publication-title: Nature reviews cancer doi: 10.1038/nrc798 – volume: 122 start-page: 902 issue: 6 year: 2004 ident: 10.1016/j.critrevonc.2022.103675_bib18 article-title: Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer publication-title: Am. J. Clin. Pathol. doi: 10.1309/VQXFT880JXC7QD2W – volume: 278 start-page: 26765 issue: 29 year: 2003 ident: 10.1016/j.critrevonc.2022.103675_bib162 article-title: Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction publication-title: J. Biol. Chem. doi: 10.1074/jbc.M303608200 – volume: 20 start-page: 435 issue: 4 year: 2013 ident: 10.1016/j.critrevonc.2022.103675_bib126 article-title: Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53 publication-title: Gene Ther. doi: 10.1038/gt.2012.54 – volume: 7 issue: 3 year: 2012 ident: 10.1016/j.critrevonc.2022.103675_bib24 article-title: HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis publication-title: PLoS One doi: 10.1371/journal.pone.0033585 – volume: 10 start-page: 143 issue: 3 year: 2013 ident: 10.1016/j.critrevonc.2022.103675_bib129 article-title: Development of PI3K inhibitors: lessons learned from early clinical trials. Nature reviews publication-title: Clin. Oncol. – volume: 10 issue: 12 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib140 article-title: Expression of suppressor of cytokine signaling 1 (SOCS1) impairs viral clearance and exacerbates lung injury during influenza infection publication-title: PLoS Pathogens doi: 10.1371/journal.ppat.1004560 – volume: 14 start-page: 193 issue: 1 year: 2021 ident: 10.1016/j.critrevonc.2022.103675_bib26 article-title: Targeted disruption of E6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against HPV-transformed cancer cells publication-title: Cancers doi: 10.3390/cancers14010193 – volume: 8 start-page: 96323 issue: 56 year: 2017 ident: 10.1016/j.critrevonc.2022.103675_bib171 article-title: Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation publication-title: Oncotarget doi: 10.18632/oncotarget.22036 – volume: 157 start-page: 1262 issue: 6 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib73 article-title: Development and applications of CRISPR-Cas9 for genome engineering publication-title: Cell doi: 10.1016/j.cell.2014.05.010 – ident: 10.1016/j.critrevonc.2022.103675_bib44 doi: 10.1073/pnas.0505322102 – volume: 20 start-page: 8244 issue: 21 year: 2000 ident: 10.1016/j.critrevonc.2022.103675_bib105 article-title: Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.20.21.8244-8253.2000 – volume: 78 start-page: 3009 issue: Pt 11 year: 1997 ident: 10.1016/j.critrevonc.2022.103675_bib132 article-title: Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis publication-title: J. Gen. Virol. doi: 10.1099/0022-1317-78-11-3009 – volume: 218 start-page: 114 issue: 1 year: 1996 ident: 10.1016/j.critrevonc.2022.103675_bib51 article-title: Analysis of HPV1 E4 complexes and their association with keratinsin vivo publication-title: Virology doi: 10.1006/viro.1996.0171 – volume: 77 start-page: 673 issue: 1 year: 2003 ident: 10.1016/j.critrevonc.2022.103675_bib128 article-title: The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts publication-title: J. Virol. doi: 10.1128/JVI.77.1.673-684.2003 – volume: 10 start-page: 3116 year: 2020 ident: 10.1016/j.critrevonc.2022.103675_bib113 article-title: Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy publication-title: Front. Microbiol. doi: 10.3389/fmicb.2019.03116 – volume: 144 start-page: 1941 issue: 8 year: 2019 ident: 10.1016/j.critrevonc.2022.103675_bib55 article-title: Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods publication-title: Int. J. Cancer doi: 10.1002/ijc.31937 – volume: 14 start-page: 36 issue: 1 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib75 article-title: Regulation of type I interferon responses publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3581 – volume: 15 start-page: 989 issue: 8 year: 2016 ident: 10.1016/j.critrevonc.2022.103675_bib166 article-title: Current state in the development of candidate therapeutic HPV vaccines publication-title: Exp. Rev. Vaccines doi: 10.1586/14760584.2016.1157477 – year: 2022 ident: 10.1016/j.critrevonc.2022.103675_bib89 article-title: Structural and biochemical analysis of the PTPN4 PDZ domain bound to the C-terminal tail of the human papillomavirus E6 oncoprotein publication-title: J. Microbiol. doi: 10.1007/s12275-022-1606-1 – volume: 39 start-page: 1547 issue: 4 year: 2018 ident: 10.1016/j.critrevonc.2022.103675_bib115 article-title: Novel structural approaches concerning HPV proteins: Insight into targeted therapies for cervical cancer publication-title: Oncol. Rep. – volume: 23 start-page: 350 issue: 2 year: 2004 ident: 10.1016/j.critrevonc.2022.103675_bib5 article-title: E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells publication-title: Oncogene doi: 10.1038/sj.onc.1207148 – volume: 143 year: 2019 ident: 10.1016/j.critrevonc.2022.103675_bib45 article-title: Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer publication-title: Prostaglandins Other Lipid Med. – volume: 157 year: 2021 ident: 10.1016/j.critrevonc.2022.103675_bib123 article-title: Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2020.103192 – volume: 24 start-page: 171 year: 2022 ident: 10.1016/j.critrevonc.2022.103675_bib147 article-title: Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells publication-title: Mol. Ther. Oncol. doi: 10.1016/j.omto.2021.12.011 – volume: 102 start-page: 522 issue: 2 year: 2007 ident: 10.1016/j.critrevonc.2022.103675_bib46 article-title: Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP‐1 and NFκB transcription factors publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2007.04633.x – volume: 46 start-page: 229 issue: 1 year: 2018 ident: 10.1016/j.critrevonc.2022.103675_bib36 article-title: The human papillomavirus DNA helicase E1 binds, stimulates, and confers processivity to cellular DNA polymerase epsilon publication-title: Nucl. Acids Res. doi: 10.1093/nar/gkx1103 – volume: 20 start-page: 604 issue: 4 year: 2012 ident: 10.1016/j.critrevonc.2022.103675_bib169 article-title: Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53 publication-title: Structure doi: 10.1016/j.str.2012.02.001 – volume: 14 start-page: 21 issue: 1 year: 2018 ident: 10.1016/j.critrevonc.2022.103675_bib39 article-title: Human papillomavirus types 16 and 18 early-expressed proteins differentially modulate the cellular redox state and DNA damage publication-title: Int. J. Biol. Sci. doi: 10.7150/ijbs.21547 – volume: 145 start-page: 2183 issue: 10 year: 2000 ident: 10.1016/j.critrevonc.2022.103675_bib108 article-title: Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation publication-title: Arch. Virol. doi: 10.1007/s007050070048 – volume: 277 start-page: 21730 issue: 24 year: 2002 ident: 10.1016/j.critrevonc.2022.103675_bib56 article-title: The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis publication-title: J. Biol.BChem. doi: 10.1074/jbc.M200113200 – volume: 30 start-page: 753 issue: 5 year: 2009 ident: 10.1016/j.critrevonc.2022.103675_bib85 article-title: Involvement of NF-κB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein publication-title: Carcinogenesis doi: 10.1093/carcin/bgp066 – volume: 286 start-page: 23 issue: 1 year: 2001 ident: 10.1016/j.critrevonc.2022.103675_bib121 article-title: Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt publication-title: Virology doi: 10.1006/viro.2001.0867 – volume: 10 start-page: 53 issue: 1 year: 2021 ident: 10.1016/j.critrevonc.2022.103675_bib4 article-title: The efficacy of therapeutic DNA vaccines expressing the human papillomavirus E6 and E7 oncoproteins for treatment of cervical publication-title: Cancer System. Rev. Vaccines – ident: 10.1016/j.critrevonc.2022.103675_bib62 doi: 10.1073/pnas.97.23.12513 – volume: 88 start-page: 4173 issue: 8 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib127 article-title: Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes publication-title: J. Virol. doi: 10.1128/JVI.02546-13 – volume: 6 start-page: 45 issue: 1 year: 2011 ident: 10.1016/j.critrevonc.2022.103675_bib163 article-title: HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress publication-title: Future Virol. doi: 10.2217/fvl.10.73 – volume: 9 start-page: 1 issue: 1 year: 2019 ident: 10.1016/j.critrevonc.2022.103675_bib25 article-title: The Human Papillomavirus (HPV) E1 protein regulates the expression of cellular genes involved in immune response publication-title: Sci. Rep. doi: 10.1038/s41598-019-49886-4 – volume: 5 start-page: e02234 issue: 6 year: 2014 ident: 10.1016/j.critrevonc.2022.103675_bib155 article-title: Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B publication-title: MBio doi: 10.1128/mBio.02234-14 – volume: 79 start-page: 7889 issue: 12 year: 2005 ident: 10.1016/j.critrevonc.2022.103675_bib154 article-title: Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1; Su (H); Lag-1 activation publication-title: J. Virol. doi: 10.1128/JVI.79.12.7889-7898.2005 – volume: 26 start-page: 7386 issue: 52 year: 2007 ident: 10.1016/j.critrevonc.2022.103675_bib29 article-title: The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Akt-dependent manner publication-title: Oncogene doi: 10.1038/sj.onc.1210541
SSID	ssj0004467
Score	2.6476572
SecondaryResourceType	review_article
Snippet	Cervical cancer (CC), one of the major causes of death of women throughout the world is primarily caused due to Human Papilloma Virus (HPV) 16 and 18. The...
SourceID	proquest pubmed crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	103675
SubjectTerms	Cervical cancer E proteins HPV Molecular mechanisms Signaling pathways Therapeutic targets
Title	Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S1040842822000993 https://dx.doi.org/10.1016/j.critrevonc.2022.103675 https://www.ncbi.nlm.nih.gov/pubmed/35381343 https://www.proquest.com/docview/2647654158
Volume	174
WOSCitedRecordID	wos000802026300003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1879-0461 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004467 issn: 1040-8428 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6DSFeJj5H-ZiMxNuUaomT2BlPBTYNRKuJjalvkeM4aqqRTm32JfH_8W9x_kpaYKIg8WJVkc6Je7_cnZ3f3SH0WgpCiB9loAFaeCHzfY-zJPYEuA6whhGLddnF0090OGSjUXLU6Xx3uTCXZ7Sq2PV1cv5fVQ3XQNkqdfYv1N1MChfgNygdRlA7jCspfiBVMq-uv9xwBw-PTj1uFQERptRVjXWJhtIQyYU2GapWiEKBbh05cI1zVe3V8RW_MdWcDXVcatqly9zamdeu4sRisNu0UbAlT9WNppWw-TEHulzs0qn-2zGva64SwSaGH_SZj1vi4nuTe3bMsxsOoxiX7Qn__Eo3Ltg5_jqDBwJzmI8bfzPk5uyoPysnZb14zAE75IaOZS2zoj6y0GaSO9NNwwXj64M3Nm1YfvEL5ohi0gNLXMOaYa09dZNeK7JcivsnF9kQFx0nbpK2M6VqptTMtIY2AholYF43-h_2Rx_bFN1QNzNuVmFJZYZq-Punui1Sum0npCOik_to025lcN9A8AHqyOohujuwZI1H6NsCErFCIp4WeBmJWCMROyTissIOidggcQ83OMQOhxhwiB0O8QIOcYvDx-jLwf7Ju0PPNvvwBFiI2iO7GROM6A_tsQiijMehFDRjMpJJUiQsZgVsfUUeCz_geZQQkvkJyygEuEVQUPIErVfTSj5FOJdxmEGk6oc0CHkWZBCEyzwjYZDvcj8nXUTdH5sKWwlfNWQ5S_-k3i7yG8lzUw1mBZnE6S512c7gn1OA5gqybxpZGxGbSHdF6VcOKik4DfUlkFdyejFPYRdE4whid9ZFWwZDzXoIhEA-Ccmzf1jrc3SvfXdfoPV6diFfojvisi7ns220Rkds274ZPwAeV_gj
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanistic+role+of+HPV-associated+early+proteins+in+cervical+cancer%3A+Molecular+pathways+and+targeted+therapeutic+strategies&rft.jtitle=Critical+reviews+in+oncology%2Fhematology&rft.au=Bhattacharjee%2C+Rahul&rft.au=Das%2C+Sabya+Sachi&rft.au=Biswal%2C+Smruti+Sudha&rft.au=Nath%2C+Arijit&rft.date=2022-06-01&rft.issn=1040-8428&rft.volume=174&rft.spage=103675&rft_id=info:doi/10.1016%2Fj.critrevonc.2022.103675&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_critrevonc_2022_103675
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1040-8428&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1040-8428&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1040-8428&client=summon